kw,qid,label,mode,exact_label,exact_alias,ctx,sl_log1p,p31_cnt,p279_cnt,ctx_p31,ctx_p279,alias_inv,w_ctx,w_sl,w_p31,w_p279,w_ctx_p31,w_ctx_p279,w_alias_inv,bonus_label,bonus_alias,total
computer game,Q7889,video game,alias,0,1,2.0,5.07,2.0,14.0,45.3,26.4,0.222,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,61.46
computer game,Q4485157,PC game,alias,0,1,4.0,3.93,0.0,11.0,0.0,31.9,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,58.21
computer game,Q659563,video game genre,none,0,0,6.0,3.71,1.0,4.0,39.7,46.5,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.69
computer game,Q1224999,educational video game,none,0,0,4.0,2.94,1.0,14.0,36.0,27.3,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,16.72
computer game,Q1062702,video game music,none,0,0,4.0,3.3,1.0,2.0,47.1,45.7,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.78
computer game,Q18882335,video game designer,none,0,0,10.0,1.1,2.0,5.0,44.6,46.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,18.71
computer game,Q18328126,video game award,none,0,0,4.0,0.69,1.0,6.0,37.2,41.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.25
computer game,Q96240590,video game bundle,none,0,0,8.0,0.0,0.0,9.0,0.0,33.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.27
computer game,Q7927908,video game accessory,none,0,0,4.0,1.61,0.0,5.0,0.0,40.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.59
computer game,Q77080538,video game term,none,0,0,6.0,0.0,0.0,3.0,0.0,46.9,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.58
computer game,Q50572288,speculative fiction video game,none,0,0,6.0,0.0,2.0,8.0,49.0,30.2,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.0
computer game,Q5157439,Computer Games,none,0,0,2.0,1.1,1.0,0.0,37.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.12
computer game,Q106460805,"Computer Games and Digital Cultures Conference, June 6-8, 2002, Tampere, Finland",none,0,0,2.0,0.0,1.0,0.0,47.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
computer game,Q106244257,"Computer Games: AI, Animation, Mobile, Multimedia, Educational and Serious Games , CGAMES 2015, Louisville, KY, USA, July 27-29, 2015",none,0,0,2.0,0.0,1.0,0.0,47.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
computer game,Q64597818,Computer Games to Prevent Mild Cognitive Impairment and Dementia,none,0,0,4.0,0.0,1.0,0.0,42.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.02
computer game,Q106903293,Computer games and learning: a Futurelab handbook,none,0,0,6.0,0.0,1.0,0.0,42.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.42
computer game,Q113926088,Computer Game-based Exercise Program Targeting Manual Dexterity for People With Spinal Cord Injury or Stroke.,none,0,0,2.0,0.0,1.0,0.0,42.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.62
computer game,Q126392228,game asset,none,0,0,4.0,0.0,0.0,6.0,0.0,41.3,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.59
computer game,Q123307305,Computer Games,none,0,0,2.0,0.0,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.61
computer game,Q1154933,Game Developers Conference,none,0,0,2.0,3.18,1.0,4.0,34.7,44.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.89
blind,Q10874,blindness,none,0,0,2.0,4.85,2.0,11.0,45.5,38.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.79
blind,Q12731,dead end street,none,0,0,0.0,3.71,2.0,5.0,41.3,42.3,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.81
blind,Q392,Bob Dylan,none,0,0,0.0,5.21,1.0,0.0,44.3,0.0,0.118,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.2
blind,Q895871,cortical blindness,none,0,0,0.0,2.4,1.0,4.0,45.6,44.3,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.41
blind,Q2244608,bird hide,alias,0,1,2.0,2.71,0.0,9.0,0.0,34.7,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,44.55
blind,Q8193177,blind person,none,0,0,4.0,2.2,0.0,2.0,0.0,46.7,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.07
blind,Q272031,Jack White,none,0,0,0.0,3.89,1.0,0.0,44.3,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.65
blind,Q183660,Anguis fragilis,none,0,0,2.0,4.33,1.0,0.0,42.3,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
blind,Q22109237,Richard A. B. Leschen,none,0,0,4.0,0.69,1.0,0.0,44.3,0.0,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.82
blind,Q19858482,Blindspot,none,0,0,0.0,3.56,1.0,0.0,42.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.0
blind,Q28936014,school for the blind,none,0,0,6.0,1.39,0.0,5.0,0.0,43.1,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.44
blind,Q37040221,Blind,label,1,0,0.0,0.69,1.0,0.0,45.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.76
blind,Q135378,Astyanax mexicanus,none,0,0,2.0,3.3,1.0,0.0,42.3,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.13
blind,Q514914,Blindheim,none,0,0,2.0,3.69,1.0,0.0,32.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.37
blind,Q15856,olm,none,0,0,2.0,4.06,1.0,0.0,42.3,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.32
blind,Q2557968,Ślepowron,none,0,0,2.0,2.3,1.0,0.0,33.9,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.19
blind,Q152540,Blind Guardian,none,0,0,0.0,3.83,1.0,0.0,33.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
blind,Q2375956,blind loop syndrome,none,0,0,8.0,2.08,1.0,4.0,45.6,44.5,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.32
blind,Q884353,blind shaft,none,0,0,8.0,2.08,0.0,3.0,0.0,43.7,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.54
blind,Q1339380,John Fahey,none,0,0,0.0,2.83,1.0,0.0,44.3,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.52
blind,Q670328,Blindenmarkt,none,0,0,2.0,3.4,2.0,0.0,43.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.13
blind,Q182458,anthracite,none,0,0,4.0,4.28,0.0,4.0,0.0,44.9,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.24
blind,Q712586,Blind Willie Johnson,none,0,0,0.0,3.26,1.0,0.0,44.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.37
blind,Q2707267,Blind,label,1,0,0.0,2.48,1.0,0.0,37.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,36.76
blind,Q906264,phthisis bulbi,none,0,0,0.0,2.2,1.0,3.0,45.6,43.9,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.71
blind,Q4493605,blind soccer,none,0,0,4.0,3.14,2.0,5.0,43.6,44.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.76
blind,Q15788974,Blindia,none,0,0,2.0,2.08,1.0,0.0,42.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.66
blind,Q19928333,The blind man,alias,0,1,2.0,1.39,1.0,0.0,38.2,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,34.17
blind,Q1246050,visual verbal agnosia,none,0,0,12.0,3.0,2.0,13.0,45.5,24.4,0.08,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,26.19
blind,Q950591,scotoma,none,0,0,0.0,3.0,1.0,10.0,45.6,34.3,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.63
blind,Q27554412,Blind Channel,none,0,0,0.0,3.43,1.0,0.0,22.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.74
blind,Q2116071,Blindcrake,none,0,0,2.0,2.71,2.0,0.0,47.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.83
blind,Q7930717,village lock-up,none,0,0,6.0,1.79,0.0,4.0,0.0,39.9,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.67
blind,Q884271,blindness and education,none,0,0,4.0,3.14,0.0,5.0,0.0,46.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.59
blind,Q19911450,Blind Orion Searching for the Rising Sun,none,0,0,4.0,2.2,1.0,0.0,38.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.08
blind,Q1362310,Tasman Bay / Te Tai-o-Aorere,none,0,0,4.0,2.77,1.0,0.0,32.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.52
blind,Q779725,Samael,none,0,0,2.0,3.58,2.0,0.0,39.4,0.0,0.105,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.5
blind,Q548656,Blind Faith,none,0,0,0.0,3.37,1.0,0.0,33.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.82
blind,Q181689,Blind Willie McTell,none,0,0,0.0,3.14,1.0,0.0,44.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.31
blind,Q37979907,Blind,label,1,0,0.0,0.0,1.0,0.0,38.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,26.84
blind,Q616100,speakeasy,none,0,0,2.0,3.26,0.0,3.0,0.0,44.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.69
blind,Q45001,Blind Lemon Jefferson,none,0,0,0.0,3.33,1.0,0.0,44.3,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.66
blind,Q608510,blind experiment,none,0,0,8.0,3.53,0.0,3.0,0.0,44.2,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.72
blind,Q884102,Blind,label,1,0,0.0,1.1,1.0,0.0,33.5,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.13
blind,Q269829,placebo,none,0,0,0.0,4.29,3.0,6.0,41.1,30.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.3
blind,Q121041,appendicite,none,0,0,0.0,4.5,2.0,10.0,48.0,29.3,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.06
blind,Q25375,Odonata,none,0,0,0.0,4.76,1.0,0.0,42.3,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.27
blind,Q9656,appendice iléo-cæcal,none,0,0,0.0,4.28,2.0,5.0,44.4,39.5,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.36
blind,Q9690,fatigue,none,0,0,0.0,4.34,2.0,7.0,49.3,36.4,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.96
blind,Q1937453,blindage mécanique,none,0,0,0.0,2.71,0.0,4.0,0.0,45.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.31
blind,Q228241,Tabanidae,none,0,0,0.0,4.61,1.0,0.0,42.3,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.28
blind,Q864705,Miridae,none,0,0,0.0,3.61,1.0,0.0,42.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.03
blind,Q8363402,Blind,label,1,0,0.0,1.79,1.0,0.0,37.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,33.99
blind,Q2092670,The Blind Boys of Alabama,none,0,0,4.0,3.0,1.0,0.0,33.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.18
blind,Q12876,char de combat,none,0,0,0.0,5.03,2.0,3.0,45.8,44.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.58
blind,Q4926494,Blind,label,1,0,0.0,1.39,1.0,0.0,37.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.36
blind,Q884108,Blind,label,1,0,0.0,1.39,2.0,0.0,46.0,0.0,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.56
blind,Q884163,Blind Melon,none,0,0,0.0,3.04,1.0,0.0,33.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.66
blind,Q868534,munition antiblindage,none,0,0,4.0,3.37,1.0,3.0,42.7,42.5,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.6
blind,Q63173593,véhicule blindé,none,0,0,0.0,1.79,1.0,2.0,40.5,47.2,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.68
blind,Q23022163,Blind,label,1,0,0.0,1.1,1.0,0.0,37.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.21
blind,Q39079093,Blind,label,1,0,2.0,1.1,2.0,0.0,49.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,39.48
blind,Q4859518,Blind River,none,0,0,0.0,2.64,1.0,0.0,42.8,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.05
blind,Q708548,Arthur Baker,none,0,0,0.0,2.56,1.0,0.0,44.3,0.0,0.118,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.88
blind,Q79894,braille,none,0,0,2.0,4.69,5.0,2.0,38.4,45.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.7
blind,Q105091262,Blind,label,1,0,0.0,0.69,1.0,0.0,44.3,0.0,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,27.75
blind,Q2738491,Blindalys,none,0,0,0.0,1.79,1.0,2.0,15.3,29.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.78
blind,Q4926602,Blind Pig Records,none,0,0,2.0,2.08,1.0,0.0,42.2,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.66
blind,Q742396,Blind Blake,none,0,0,0.0,2.94,1.0,0.0,44.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.72
blind,Q2047597,Blindbothel,none,0,0,0.0,2.56,2.0,0.0,47.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.36
visually disabled,Q16649002,person with visual disabilities,none,0,0,10.0,1.1,0.0,2.0,0.0,40.6,0.051,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.23
theorie DES probabilites,Q5862903,probability theory,none,0,0,2.4,4.55,2.0,2.0,28.2,36.1,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.75
telecommunication,Q418,telecommunications,none,0,0,3.2,4.91,3.0,2.0,41.3,36.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.63
telecommunication,Q29565491,Telecommunications Institute,none,0,0,1.6,0.0,1.0,0.0,23.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.97
telecommunication,Q2401749,telecommunication company,none,0,0,3.2,1.61,0.0,11.0,0.0,48.6,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.41
telecommunication,Q1061219,telecommunications engineering,none,0,0,4.8,3.47,3.0,2.0,46.8,40.2,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.93
telecommunication,Q1266169,telephone company,none,0,0,4.0,3.09,0.0,11.0,0.0,49.5,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.88
telecommunication,Q1068715,telecommunications network,none,0,0,2.4,3.56,0.0,5.0,0.0,48.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.66
telecommunication,Q1798641,communication tower,none,0,0,3.2,1.61,0.0,11.0,0.0,48.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.16
telecommunication,Q12246069,telecommunications engineer,none,0,0,0.8,0.69,2.0,4.0,35.2,30.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.91
telecommunication,Q1780509,telecommunications device,none,0,0,4.8,2.89,0.0,3.0,0.0,43.9,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.95
telecommunication,Q1144084,utility pole,none,0,0,2.4,3.18,1.0,8.0,28.6,47.7,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.31
telecommunication,Q55273934,Telecommunications Numbering Plan 2015,none,0,0,3.2,0.0,1.0,0.0,31.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.98
telecommunication,Q204043,teleportation,none,0,0,4.0,4.08,1.0,5.0,19.9,47.3,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.11
telecommunication,Q100399399,"Telecommunications (Miscellaneous Provisions) Act, 1996",none,0,0,2.4,0.0,1.0,0.0,29.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.0
telecommunication,Q46622804,telecommunications building,none,0,0,2.4,0.0,0.0,4.0,0.0,47.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.69
telecommunication,Q3833047,telecommunications link,none,0,0,2.4,2.89,0.0,4.0,0.0,44.4,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.3
telecommunication,Q11897515,telecommunications technology,none,0,0,0.8,1.1,0.0,4.0,0.0,46.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.29
telecommunication,Q7695840,Telecommunication,label,1,0,1.6,1.1,1.0,0.0,21.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,35.7
telecommunication,Q7696092,telecommunications service provider,none,0,0,2.4,1.39,0.0,8.0,0.0,48.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.78
telecommunication,Q3467747,telecommunications service,none,0,0,1.6,2.3,1.0,2.0,17.9,33.6,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.73
telecommunication,Q17597352,Telecommunications Technology Center of Catalonia,none,0,0,2.4,0.69,1.0,0.0,23.8,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.79
telecommunication,Q2750030,history of telecommunication,none,0,0,2.4,2.64,1.0,6.0,25.0,44.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.23
telecommunication,Q78043953,telecommunications engineering degree,none,0,0,1.6,0.0,2.0,0.0,32.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.86
telecommunication,Q354147,telecommunications device for the deaf,none,0,0,2.4,2.2,0.0,7.0,0.0,50.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.61
telecommunication,Q5702359,communications law,none,0,0,3.2,1.1,1.0,3.0,21.3,39.9,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.3
telecommunication,Q7695853,Telecommunications Act 1984,none,0,0,2.4,0.69,1.0,0.0,26.9,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.82
telecommunication,Q52987314,telecommunications museum,none,0,0,1.6,0.0,0.0,2.0,0.0,28.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.37
telecommunication,Q58325931,telecommunications policy,none,0,0,0.8,0.0,1.0,4.0,17.9,47.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.22
telecommunication,Q1668014,telecommunications in India,none,0,0,3.2,2.3,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.1
telecommunication,Q380278,phone fraud,none,0,0,2.4,2.48,0.0,5.0,0.0,48.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.03
telecommunication,Q7695847,telecommunication circuit,none,0,0,2.4,1.95,0.0,3.0,0.0,42.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.52
telecommunication,Q55445402,telecommunications in Belarus,none,0,0,3.2,1.95,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.93
telecommunication,Q56758598,Telecommunications Legislation Amendment (Deregulation) Act 2015,none,0,0,3.2,0.0,1.0,0.0,22.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.89
telecommunication,Q107191142,telecommunications law,none,0,0,3.2,0.0,1.0,3.0,21.3,43.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.03
telecommunication,Q99069260,TDD number,none,0,0,5.6,0.0,0.0,7.0,0.0,52.1,0.118,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.74
telecommunication,Q56758567,Telecommunications and Postal Services (Transitional Provisions and Consequential Amendments) Act 1989,none,0,0,4.0,0.0,1.0,0.0,22.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.86
telecommunication,Q2142580,telecommunications relay service,none,0,0,5.6,2.08,0.0,2.0,0.0,37.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.81
telecommunication,Q115748315,"telecommunications, broadcasting and information supply services",none,0,0,4.0,0.0,1.0,2.0,14.2,33.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.25
telecommunication,Q492890,telecommunications in South Korea,none,0,0,3.2,1.79,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.85
telecommunication,Q18166107,Telecommunications (Interception and Access) Act 1979,none,0,0,4.0,0.69,1.0,0.0,22.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.21
telecommunication,Q1778694,Telecommunications Act of 1996,none,0,0,3.2,2.2,1.0,0.0,26.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.23
telecommunication,Q18328135,STENTOR,none,0,0,4.8,1.39,3.0,0.0,41.8,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.52
telecommunication,Q376223,Telecommunications Research Establishment,none,0,0,0.8,1.95,1.0,0.0,38.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.12
telecommunication,Q112165959,télécommunications filaires,none,0,0,0.0,0.0,1.0,2.0,20.6,24.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.9
telecommunication,Q958957,étalement de spectre,none,0,0,0.0,3.3,1.0,6.0,24.4,52.1,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.21
telecommunication,Q2401742,télécommunications,none,0,0,0.0,2.56,1.0,4.0,20.6,40.7,0.077,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.25
telecommunication,Q29584761,Télécommunications par satellite,none,0,0,0.0,0.69,1.0,3.0,20.6,37.2,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.2
telecommunication,Q7695940,télécommunications en Allemagne,none,0,0,2.4,1.61,1.0,0.0,28.2,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.65
telecommunication,Q4202085,Télécommunications en Azerbaïdjan,none,0,0,3.2,2.2,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.05
telecommunication,Q7696083,télécommunications au Royaume-Uni,none,0,0,4.0,1.39,1.0,0.0,28.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.61
telecommunication,Q112165961,télécommunications sans fil,none,0,0,0.0,0.0,1.0,2.0,20.6,25.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.41
telecommunication,Q7695910,télécommunications au Canada,none,0,0,3.2,1.39,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.65
telecommunication,Q4165779,télécommunications en Algérie,none,0,0,0.8,1.1,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
telecommunication,Q112128677,télécommunications sans fil,none,0,0,0.0,0.69,1.0,2.0,20.6,36.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.05
telecommunication,Q5780459,télécommunications en Islande,none,0,0,3.2,1.39,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.65
telecommunication,Q29584759,Télécommunications filaires,none,0,0,0.0,0.0,1.0,3.0,20.6,37.2,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.85
telecommunication,Q4411280,Télécommunications au Nigeria,none,0,0,0.8,2.08,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.09
telecommunication,Q7695842,Telecommunication Company of Iran,none,0,0,0.8,1.95,1.0,0.0,28.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.03
telecommunication,Q5617083,télécommunications en Suisse,none,0,0,3.2,1.79,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.85
telecommunication,Q5761637,Télécommunications au Ghana,none,0,0,0.8,1.79,1.0,0.0,28.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.95
telecommunication,Q29584760,télécommunications sans fil,none,0,0,0.0,0.0,1.0,3.0,20.6,37.2,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.96
telecommunication,Q112165963,télécommunications par satellite,none,0,0,0.0,0.0,1.0,2.0,20.6,37.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.01
telecommunication,Q17485293,télécommunications en France,none,0,0,0.0,1.61,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.89
reseau DE telecommunications,Q7277883,RTSS,none,0,0,1.6,0.69,1.0,0.0,34.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.93
reseau DE telecommunications,Q1068715,telecommunications network,none,0,0,2.4,3.56,0.0,5.0,0.0,48.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.66
incertitude,Q13649246,uncertainty,alias,0,1,5.6,3.93,4.0,8.0,45.2,47.8,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,68.93
incertitude,Q1403517,measurement uncertainty,none,0,0,3.2,3.37,2.0,3.0,37.4,44.2,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.68
incertitude,Q11791657,expanded uncertainty,none,0,0,2.4,0.69,0.0,2.0,0.0,43.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.3
incertitude,Q3149860,absolute uncertainty,alias,0,1,3.2,0.69,1.0,2.0,84.8,43.9,1.0,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,41.24
incertitude,Q3149861,relative uncertainty,none,0,0,4.0,0.69,1.0,2.0,84.8,43.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.38
incertitude,Q11791656,standard measurement uncertainty,none,0,0,2.4,0.69,0.0,2.0,0.0,43.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.3
incertitude,Q2919796,clinical equipoise,none,0,0,8.9,1.61,1.0,0.0,27.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.52
incertitude,Q18465251,uncertainty in science,none,0,0,1.6,1.1,1.0,3.0,84.8,44.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.29
incertitude,Q110721842,combined standard measurement uncertainty,none,0,0,0.8,0.0,0.0,2.0,0.0,39.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.48
incertitude,Q110773970,target measurement uncertainty,none,0,0,0.8,0.0,0.0,2.0,0.0,43.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.02
telecommunication,Q418,telecommunications,none,0,0,1.7,4.91,3.0,2.0,34.9,44.6,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.79
telecommunication,Q29565491,Telecommunications Institute,none,0,0,1.1,0.0,1.0,0.0,18.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.33
telecommunication,Q2401749,telecommunication company,none,0,0,2.8,1.61,0.0,11.0,0.0,49.7,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.92
telecommunication,Q1061219,telecommunications engineering,none,0,0,4.5,3.47,3.0,2.0,43.8,33.7,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.43
telecommunication,Q1266169,telephone company,none,0,0,2.8,3.09,0.0,11.0,0.0,51.6,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.43
telecommunication,Q1068715,telecommunications network,none,0,0,1.7,3.56,0.0,5.0,0.0,40.7,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.73
telecommunication,Q1798641,communication tower,none,0,0,3.4,1.61,0.0,11.0,0.0,52.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.37
telecommunication,Q12246069,telecommunications engineer,none,0,0,0.6,0.69,2.0,4.0,28.6,23.3,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
telecommunication,Q1780509,telecommunications device,none,0,0,2.8,2.89,0.0,3.0,0.0,38.1,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.47
telecommunication,Q1144084,utility pole,none,0,0,1.7,3.18,1.0,8.0,28.6,48.4,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.43
telecommunication,Q55273934,Telecommunications Numbering Plan 2015,none,0,0,2.2,0.0,1.0,0.0,16.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.67
telecommunication,Q204043,teleportation,none,0,0,2.8,4.08,1.0,5.0,41.1,40.5,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.8
telecommunication,Q100399399,"Telecommunications (Miscellaneous Provisions) Act, 1996",none,0,0,1.7,0.0,1.0,0.0,29.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.12
telecommunication,Q46622804,telecommunications building,none,0,0,1.1,0.0,0.0,4.0,0.0,42.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.09
telecommunication,Q3833047,telecommunications link,none,0,0,2.8,2.89,0.0,4.0,0.0,38.7,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.73
telecommunication,Q11897515,telecommunications technology,none,0,0,1.1,1.1,0.0,4.0,0.0,41.6,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.63
telecommunication,Q7695840,Telecommunication,label,1,0,1.7,1.1,1.0,0.0,15.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,35.78
telecommunication,Q7696092,telecommunications service provider,none,0,0,1.7,1.39,0.0,8.0,0.0,50.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.92
telecommunication,Q3467747,telecommunications service,none,0,0,1.1,2.3,1.0,2.0,9.3,28.6,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.02
telecommunication,Q17597352,Telecommunications Technology Center of Catalonia,none,0,0,2.2,0.69,1.0,0.0,18.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.52
telecommunication,Q2750030,history of telecommunication,none,0,0,2.2,2.64,1.0,6.0,18.4,39.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.92
telecommunication,Q78043953,telecommunications engineering degree,none,0,0,1.1,0.0,2.0,0.0,27.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.22
telecommunication,Q354147,telecommunications device for the deaf,none,0,0,2.2,2.2,0.0,7.0,0.0,48.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.38
telecommunication,Q5702359,communications law,none,0,0,3.9,1.1,1.0,3.0,20.1,34.5,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.1
telecommunication,Q7695853,Telecommunications Act 1984,none,0,0,1.7,0.69,1.0,0.0,25.9,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.93
telecommunication,Q52987314,telecommunications museum,none,0,0,1.7,0.0,0.0,2.0,0.0,25.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.43
telecommunication,Q58325931,telecommunications policy,none,0,0,0.6,0.0,1.0,4.0,9.3,43.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.82
telecommunication,Q1668014,telecommunications in India,none,0,0,1.7,2.3,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.18
telecommunication,Q380278,phone fraud,none,0,0,2.2,2.48,0.0,5.0,0.0,44.4,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.79
telecommunication,Q7695847,telecommunication circuit,none,0,0,2.2,1.95,0.0,3.0,0.0,35.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.25
telecommunication,Q55445402,telecommunications in Belarus,none,0,0,1.7,1.95,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.0
telecommunication,Q56758598,Telecommunications Legislation Amendment (Deregulation) Act 2015,none,0,0,2.2,0.0,1.0,0.0,25.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.75
telecommunication,Q107191142,telecommunications law,none,0,0,2.2,0.0,1.0,3.0,20.1,35.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.78
telecommunication,Q99069260,TDD number,none,0,0,3.4,0.0,0.0,7.0,0.0,50.5,0.118,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.0
telecommunication,Q56758567,Telecommunications and Postal Services (Transitional Provisions and Consequential Amendments) Act 1989,none,0,0,2.8,0.0,1.0,0.0,25.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.42
telecommunication,Q2142580,telecommunications relay service,none,0,0,4.5,2.08,0.0,2.0,0.0,29.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.37
telecommunication,Q115748315,"telecommunications, broadcasting and information supply services",none,0,0,2.8,0.0,1.0,2.0,9.4,25.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.67
telecommunication,Q492890,telecommunications in South Korea,none,0,0,1.7,1.79,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.92
telecommunication,Q18166107,Telecommunications (Interception and Access) Act 1979,none,0,0,2.8,0.69,1.0,0.0,25.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.77
telecommunication,Q1778694,Telecommunications Act of 1996,none,0,0,2.2,2.2,1.0,0.0,19.3,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
telecommunication,Q18328135,STENTOR,none,0,0,3.4,1.39,3.0,0.0,34.0,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.68
telecommunication,Q376223,Telecommunications Research Establishment,none,0,0,0.6,1.95,1.0,0.0,32.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.77
telecommunication,Q112165959,télécommunications filaires,none,0,0,0.6,0.0,1.0,2.0,14.7,28.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.55
telecommunication,Q958957,étalement de spectre,none,0,0,0.6,3.3,1.0,6.0,47.6,48.5,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.09
telecommunication,Q2401742,télécommunications,none,0,0,0.0,2.56,1.0,4.0,14.7,33.9,0.077,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.13
telecommunication,Q29584761,Télécommunications par satellite,none,0,0,0.6,0.69,1.0,3.0,14.7,49.2,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.91
telecommunication,Q7695940,télécommunications en Allemagne,none,0,0,1.7,1.61,1.0,0.0,20.5,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.69
telecommunication,Q4202085,Télécommunications en Azerbaïdjan,none,0,0,2.8,2.2,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.47
telecommunication,Q7696083,télécommunications au Royaume-Uni,none,0,0,2.2,1.39,1.0,0.0,20.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.4
telecommunication,Q112165961,télécommunications sans fil,none,0,0,0.6,0.0,1.0,2.0,14.7,25.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.03
telecommunication,Q7695910,télécommunications au Canada,none,0,0,1.7,1.39,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.72
telecommunication,Q4165779,télécommunications en Algérie,none,0,0,0.6,1.1,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.23
telecommunication,Q112128677,télécommunications sans fil,none,0,0,0.0,0.69,1.0,2.0,14.7,38.8,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.0
telecommunication,Q5780459,télécommunications en Islande,none,0,0,1.7,1.39,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.72
telecommunication,Q29584759,Télécommunications filaires,none,0,0,0.0,0.0,1.0,3.0,14.7,49.2,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.89
telecommunication,Q4411280,Télécommunications au Nigeria,none,0,0,1.1,2.08,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.39
telecommunication,Q7695842,Telecommunication Company of Iran,none,0,0,1.1,1.95,1.0,0.0,41.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.54
telecommunication,Q5617083,télécommunications en Suisse,none,0,0,1.7,1.79,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.92
telecommunication,Q5761637,Télécommunications au Ghana,none,0,0,1.1,1.79,1.0,0.0,20.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.25
telecommunication,Q29584760,télécommunications sans fil,none,0,0,0.0,0.0,1.0,3.0,14.7,49.2,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.0
telecommunication,Q112165963,télécommunications par satellite,none,0,0,0.6,0.0,1.0,2.0,14.7,41.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.65
telecommunication,Q17485293,télécommunications en France,none,0,0,0.6,1.61,1.0,0.0,20.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.48
incertitude,Q13649246,uncertainty,alias,0,1,5.1,3.93,4.0,8.0,40.6,48.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,67.08
incertitude,Q1403517,measurement uncertainty,none,0,0,2.2,3.37,2.0,3.0,31.4,36.9,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.39
incertitude,Q11791657,expanded uncertainty,none,0,0,1.7,0.69,0.0,2.0,0.0,38.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.37
incertitude,Q3149860,absolute uncertainty,alias,0,1,2.2,0.69,1.0,2.0,84.8,38.2,1.0,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,38.21
incertitude,Q3149861,relative uncertainty,none,0,0,2.2,0.69,1.0,2.0,84.8,38.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.2
incertitude,Q11791656,standard measurement uncertainty,none,0,0,1.7,0.69,0.0,2.0,0.0,38.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.37
incertitude,Q2919796,clinical equipoise,none,0,0,6.7,1.61,1.0,0.0,20.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.9
incertitude,Q18465251,uncertainty in science,none,0,0,1.1,1.1,1.0,3.0,84.8,36.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.64
incertitude,Q110721842,combined standard measurement uncertainty,none,0,0,0.6,0.0,0.0,2.0,0.0,31.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.13
incertitude,Q110773970,target measurement uncertainty,none,0,0,0.6,0.0,0.0,2.0,0.0,38.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.68
reseau DE telecommunications,Q7277883,RTSS,none,0,0,1.1,0.69,1.0,0.0,29.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.29
reseau DE telecommunications,Q1068715,telecommunications network,none,0,0,1.7,3.56,0.0,5.0,0.0,40.7,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.73
pharmacokinetic,Q323936,pharmacokinetics,none,0,0,2.6,3.95,1.0,10.0,30.8,47.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.6
pharmacokinetic,Q49493220,Liang Zhang,none,0,0,0.0,0.0,1.0,0.0,29.1,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,1.95
pharmacokinetic,Q7119492,PK/PD models,none,0,0,2.6,1.61,0.0,6.0,0.0,45.6,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.91
pharmacokinetic,Q39749859,pharmacokinetic parameter,none,0,0,0.7,0.0,0.0,4.0,0.0,47.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.56
pharmacokinetic,Q61955490,Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q64673283,Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
pharmacokinetic,Q61956421,Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
pharmacokinetic,Q61957032,Pharmacokinetic Study of CXB909 in Healthy Male Subjects,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q64220283,Pharmacokinetics of a Standard Paracetamol Tablet and Oral Solution After Oral Administration in Chinese Healthy Volunteers,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q61909191,Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
pharmacokinetic,Q61981421,Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q64048634,Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
pharmacokinetic,Q61967339,Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
pharmacokinetic,Q113911334,Pharmacokinetic and Safety of Antiretroviral and Related Drugs in Lactating Women and Breastmilk Fed Infants,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q61966922,Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
pharmacokinetic,Q64676195,Pharmacokinetics of Dactinomycin in Young Patients With Cancer,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q105089354,"Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)",none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pharmacokinetic,Q62042281,Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
pharmacokinetic,Q61924242,Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pharmacokinetic,Q64677468,Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A,none,0,0,4.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
pharmacokinetic,Q62822358,Pharmacokinetics of Meropenem During High-dose CRRT,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
pharmacokinetic,Q62813849,Pharmacokinetics of XueBiJing in Patients With Sepsis,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q64708941,Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q60741211,Pharmacokinetics of estradiol,none,0,0,0.7,1.1,1.0,0.0,25.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.39
pharmacokinetic,Q60741420,Pharmacokinetics of progesterone,none,0,0,0.7,1.1,1.0,0.0,25.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.39
pharmacokinetic,Q85793039,Pharmacokinetics of testosterone,none,0,0,0.7,0.69,1.0,0.0,25.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.19
pharmacokinetic,Q105493863,Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pharmacokinetic,Q102154251,PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS,none,0,0,0.7,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.82
pharmacokinetic,Q65342899,Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pharmacokinetic,Q65356084,Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q65360906,Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pharmacokinetic,Q62810996,Pharmacokinetics of Drugs Administered to Children,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
pharmacokinetic,Q62817864,Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q61918435,Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
pharmacokinetic,Q61907322,Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
pharmacokinetic,Q61956726,Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
pharmacokinetic,Q61933058,Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q61965800,"Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects",none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q63228730,Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q63582639,Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls.,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q64649238,Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
pharmacokinetic,Q64648190,Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655),none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q64641789,Pharmacokinetic Study of Fluconazole in Premature Infants,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q99956150,Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pharmacokinetic,Q93704577,Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
mathematical modeling,Q990044,epidemiological modeling,none,0,0,5.9,2.48,0.0,6.0,0.0,47.6,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.74
mathematical modeling,Q10331368,mathematical modelling,alias,0,1,2.6,2.48,0.0,3.0,0.0,41.3,0.333,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,39.07
mathematical modeling,Q113623286,Mathematical Modeling Session at the International Conference Information Technology and Nanotechnology (MM-ITNT 2017),none,0,0,2.0,0.0,2.0,0.0,38.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.33
mathematical modeling,Q112235969,Mathematical modeling for carbon dioxide level within confined spaces,none,0,0,2.0,0.0,1.0,0.0,18.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.34
mathematical modeling,Q113014441,Mathematical modeling ontology,none,0,0,1.3,0.0,1.0,0.0,26.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.63
mathematical modeling,Q113001965,Mathematical Modeling In Word Games: Apportionment of Letter Tiles,none,0,0,2.0,0.0,1.0,0.0,15.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.31
mathematical modeling,Q66065175,Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
mathematical modeling,Q66031144,Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy,none,0,0,1.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
mathematical modeling,Q26359148,"Mathematical modeling of the combined turbulent transport phenomena, chemical reactions, and thermal radiation in a flash-furnace shaft",none,0,0,3.9,0.0,1.0,0.0,18.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.69
mathematical modeling,Q26323331,Mathematical modeling of static hysteresis during inflation deflation cycles in normal and tween-rinsed excised rat lungs,none,0,0,3.3,0.0,1.0,0.0,33.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.06
mathematical modeling,Q66672329,Mathematical modeling of percutaneous absorption of volatile solvents following transient liquid-phase exposures,none,0,0,2.0,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.34
mathematical modeling,Q26358604,Mathematical modeling of spontaneous heating of a coalbed,none,0,0,2.6,0.0,1.0,0.0,21.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.15
mathematical modeling,Q26379373,Mathematical Modeling of Spontaneous Heating of Coal,none,0,0,2.0,0.0,1.0,0.0,19.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
mathematical modeling,Q65541509,Mathematical Modeling of the Acute Inflammatory Response Following Injury,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
mathematical modeling,Q66400876,Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
mathematical modeling,Q66042131,Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
mathematical modeling,Q63582559,Mathematical Modeling and Risk Factor Analysis for Mortality of Sepsis,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
mathematical modeling,Q26373457,Mathematical Modeling of Mine-dependent Radon Flux Problems,none,0,0,2.0,0.0,1.0,0.0,19.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
mathematical modeling,Q25112211,Mathematical modeling of in vivo isometric force response of skeletal muscle due to duty cycle,none,0,0,3.3,0.0,1.0,0.0,33.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.06
mathematical modeling,Q26372031,Mathematical Modeling of Spontaneous Combustion of Coal,none,0,0,2.0,0.0,1.0,0.0,19.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
mathematical modeling,Q26330743,Mathematical modeling of time dependent radon flux problems,none,0,0,2.0,0.0,1.0,0.0,18.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.34
mathematical modeling,Q26359817,Mathematical modeling of accessory element distribution in metallurgical processes--computerization of a lead smelter plant,none,0,0,2.6,0.0,1.0,0.0,21.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.15
mathematical modeling,Q65370423,Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
mathematical modeling,Q26359081,Mathematical modeling of chalcopyrite concentrate combustion in an axisymmetric flash-furnace shaft,none,0,0,2.0,0.0,1.0,0.0,18.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
mathematical modeling,Q87825364,Mathematical Modeling of Infectious Diseases Dynamics,none,0,0,1.3,0.0,1.0,0.0,25.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.63
ribavirin,Q421862,ribavirin,label,1,0,0.7,3.5,1.0,2.0,22.9,25.8,0.133,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,42.5
ribavirin,Q29006440,Ribavirin Mylan,none,0,0,0.7,0.0,2.0,0.0,42.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.81
ribavirin,Q29006441,Ribavirin Teva,none,0,0,0.7,0.0,2.0,0.0,42.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.81
ribavirin,Q29006443,Ribavirin Teva Pharma B.v.,none,0,0,0.7,0.0,2.0,0.0,42.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.81
ribavirin,Q29006439,Ribavirin Biopartners,none,0,0,0.7,0.0,2.0,0.0,42.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.81
ribavirin,Q27251538,ribavirin carboxylic acid,none,0,0,0.7,0.0,1.0,2.0,22.9,29.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.25
ribavirin,Q27285517,ribavirin monophosphate,none,0,0,0.7,0.0,1.0,2.0,22.9,27.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.24
ribavirin,Q27465138,ribavirin triphosphate,none,0,0,0.7,0.0,1.0,2.0,29.1,29.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.31
ribavirin,Q83087631,Ribavirin 5'-diphosphate,none,0,0,1.3,0.0,1.0,2.0,22.9,29.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.03
ribavirin,Q65383481,Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
ribavirin,Q64722523,Ribavirin for Hemorrhagic Fever With Renal Syndrome,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
ribavirin,Q27260032,ribavirin elaidate,none,0,0,0.7,0.0,1.0,2.0,22.9,29.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.25
ribavirin,Q83023934,"Ribavirin 3',5'-phosphate pentadecamer homoribopolymer",none,0,0,1.3,0.0,1.0,2.0,22.9,29.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.03
ribavirin,Q64222450,Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
ribavirin,Q66082421,Ribavirin Bioavailability After Telaprevir Exposure,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
ribavirin,Q66033933,Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation,none,0,0,4.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
ribavirin,Q63816839,Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
ribavirin,Q64184449,Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
ribavirin,Q66387209,Ribavirin Dose Optimization for the Treatment of Hepatitis C,none,0,0,4.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
ribavirin,Q66037113,Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
ribavirin,Q63592457,Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
ribavirin,Q66039221,Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
ribavirin,Q64694785,Ribavirin 200 mg Tablets Under Non-Fasting Conditions,none,0,0,0.7,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.82
ribavirin,Q64661167,Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
ribavirin,Q61918609,"Ribavirin, Its Dosing Regime",none,0,0,0.7,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.82
ribavirin,Q61980761,Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
ribavirin,Q67134005,Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
ribavirin,Q83019728,Ribavirin 5'-sulfamate,none,0,0,1.3,0.0,1.0,2.0,22.9,29.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.03
ribavirin,Q64694873,Ribavirin 200 mg Tablets Under Fasting Conditions,none,0,0,0.7,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.82
pegylated-interferon,Q7160835,pegylated interferon,none,0,0,2.0,2.08,2.0,0.0,29.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.28
pegylated-interferon,Q65539028,Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4,none,0,0,5.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.09
pegylated-interferon,Q61933297,Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance,none,0,0,4.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
pegylated-interferon,Q66034935,Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV),none,0,0,7.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.66
pegylated-interferon,Q92392273,Pegylated Interferon Lambda Treatment for COVID-19,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pegylated-interferon,Q113891779,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pegylated-interferon,Q65544754,Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C,none,0,0,8.5,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.23
pegylated-interferon,Q63817596,Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET),none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
pegylated-interferon,Q63830135,Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q66039490,Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q63843684,"Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients",none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q113888782,Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19),none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
pegylated-interferon,Q61917984,Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C,none,0,0,5.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.09
pegylated-interferon,Q63844116,Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB),none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
pegylated-interferon,Q64045644,Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED),none,0,0,11.8,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,18.15
pegylated-interferon,Q66039752,Pegylated Interferon to Treat Chronic Hepatitis D,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pegylated-interferon,Q66390231,Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q61969182,Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia,none,0,0,4.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
pegylated-interferon,Q64727412,Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q64216857,Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q66033166,Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
pegylated-interferon,Q63340057,Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
pegylated-interferon,Q83795495,Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q64676773,Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C,none,0,0,4.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
pegylated-interferon,Q63837586,Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
pegylated-interferon,Q65544592,Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
pegylated-interferon,Q66030264,Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q65387501,Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q65378528,Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C,none,0,0,5.2,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.31
pegylated-interferon,Q64354147,Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
protease inhibitor,Q166774,protease inhibitor,label,1,0,3.9,2.64,1.0,2.0,18.8,29.9,0.2,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,49.13
protease inhibitor,Q292982,Serpin family A member 1,none,0,0,2.6,3.33,3.0,0.0,39.2,0.0,0.105,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.91
protease inhibitor,Q87445441,protease inhibitor protein,none,0,0,2.0,0.0,1.0,9.0,18.5,44.7,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.3
protease inhibitor,Q55761529,protease inhibitor,label,1,0,5.2,2.56,2.0,7.0,36.8,44.5,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,64.15
protease inhibitor,Q4531845,tissue inhibitor of metalloproteinase,none,0,0,2.0,1.61,1.0,7.0,23.2,44.7,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.75
protease inhibitor,Q24780694,"Protease inhibitor, beta-barrel domain",none,0,0,1.3,0.0,1.0,2.0,23.0,44.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.65
protease inhibitor,Q21114772,Serine peptidase inhibitor Kazal type 6,none,0,0,2.0,1.61,1.0,0.0,23.5,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.05
protease inhibitor,Q21134307,Serpin family B member 9,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.82
protease inhibitor,Q5731649,Serpin family D member 1,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.89
protease inhibitor,Q21123899,Serpin family B member 13,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.82
protease inhibitor,Q21123885,Serpin family B member 6,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.89
protease inhibitor,Q5353128,peptidase inhibitor 3,none,0,0,2.0,1.79,1.0,0.0,23.5,0.0,0.125,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.66
protease inhibitor,Q21101249,Secretory leukocyte peptidase inhibitor,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.85
protease inhibitor,Q21172762,Epididymal peptidase inhibitor,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.125,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
protease inhibitor,Q21123888,Serpin family B member 10,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.99
protease inhibitor,Q21116063,Serpin family B member 1,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.133,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.79
protease inhibitor,Q22328557,protease inhibitor complex,none,0,0,3.3,0.0,1.0,2.0,16.5,34.4,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.36
protease inhibitor,Q6783904,Serpin family B member 5,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.77
protease inhibitor,Q21123887,Serpin family B member 4,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.6
protease inhibitor,Q21133248,Serpin family A member 4,none,0,0,3.3,0.0,1.0,5.0,23.5,37.3,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.72
protease inhibitor,Q24774148,Protease inhibitor I38,none,0,0,1.3,0.0,1.0,5.0,23.2,37.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.4
protease inhibitor,Q21123889,Serpin family B member 8,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.63
protease inhibitor,Q21988770,"Serine (or cysteine) peptidase inhibitor, clade I, member 1",none,0,0,2.6,0.0,1.0,5.0,23.5,37.3,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.14
protease inhibitor,Q21988442,Peptidase inhibitor 16,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.69
protease inhibitor,Q15320685,"Serine (or cysteine) peptidase inhibitor, clade B, member 5",none,0,0,3.3,0.0,1.0,5.0,23.5,37.3,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.8
protease inhibitor,Q62689346,"Protease inhibitor, putative",none,0,0,2.6,0.0,1.0,5.0,23.5,37.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.97
protease inhibitor,Q21136685,WAP four-disulfide core domain 12,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.92
protease inhibitor,Q21115119,Putative alpha-1-antitrypsin-related protein,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.89
protease inhibitor,Q23345273,protease inhibitor Inh PSPTO_3331,none,0,0,2.0,0.0,1.0,5.0,14.7,44.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.86
protease inhibitor,Q29525729,Peptidase inhibitor 16,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.59
protease inhibitor,Q21136686,WAP four-disulfide core domain 6,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.14
protease inhibitor,Q62291596,Protease inhibitor I4 serpin,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.69
protease inhibitor,Q21133346,Peptidase inhibitor 16,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.05
protease inhibitor,Q28558144,Serpin family I member 1,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.15
protease inhibitor,Q21988438,Peptidase inhibitor 15,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.54
protease inhibitor,Q23606143,Protease inhibitor Kazal-type Smed_1612,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.69
protease inhibitor,Q23278738,protease inhibitor protein AMED_6637,none,0,0,2.0,0.0,1.0,5.0,14.7,44.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.16
protease inhibitor,Q21136681,WAP four-disulfide core domain 11,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.59
protease inhibitor,Q30548506,Protease inhibitor Kazal-type Mesci_2183,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.39
protease inhibitor,Q64425588,TGME49_217430.1,none,0,0,2.6,0.0,1.0,5.0,23.5,37.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.47
protease inhibitor,Q29526265,Peptidase inhibitor 15,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.59
protease inhibitor,Q21136676,WAP four-disulfide core domain 8,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.77
protease inhibitor,Q29658037,piit-1,none,0,0,3.3,0.0,1.0,0.0,14.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.37
protease inhibitor,Q28562374,Serpin family D member 1,none,0,0,2.0,0.0,1.0,5.0,23.5,37.3,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.19
protease inhibitor,Q41796590,Protease inhibitor with pacifastin repeats,none,0,0,2.0,0.0,1.0,0.0,23.2,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.88
protease inhibitor,Q21121421,Serpin family I member 2,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.85
protease inhibitor,Q21136678,WAP four-disulfide core domain 10B,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.59
protease inhibitor,Q21136677,WAP four-disulfide core domain 3,none,0,0,2.0,0.0,1.0,0.0,23.5,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.25
protease inhibitor,Q62275332,EgrG_000739200.1,none,0,0,2.6,0.0,1.0,5.0,23.5,37.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.47
hepatitis c virus,Q708693,Hepatitis C virus,label,1,0,2.6,3.5,1.0,0.0,25.0,0.0,0.222,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,45.27
hepatitis c virus,Q29006893,Hepacivirus C,alias,0,1,2.6,0.0,1.0,0.0,25.0,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,30.23
hepatitis c virus,Q19000918,hepatitis C virus related hepatocellular carcinoma,none,0,0,2.0,0.0,0.0,7.0,0.0,46.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.92
hepatitis c virus,Q21133772,PCNA clamp associated factor,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.72
hepatitis c virus,Q83141840,Hepatitis C virus non-structural 5a protein family,none,0,0,2.0,1.61,2.0,10.0,30.0,41.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.89
hepatitis c virus,Q21121452,"Transcription factor B2, mitochondrial",none,0,0,3.3,0.0,1.0,0.0,23.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
hepatitis c virus,Q21498835,Aspartoacylase (aminoacylase) 3,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.67
hepatitis c virus,Q83141838,Hepatitis C virus non-structural protein NS2 family,none,0,0,2.0,1.79,2.0,3.0,30.0,19.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.61
hepatitis c virus,Q21130568,Chromosome 1 open reading frame 43,none,0,0,3.9,0.0,1.0,0.0,23.5,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.41
hepatitis c virus,Q28110424,Mediator of cell motility 1,none,0,0,3.3,0.0,1.0,5.0,23.5,37.3,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.01
hepatitis c virus,Q21171937,BTB domain containing 1,none,0,0,3.3,0.0,1.0,5.0,23.5,37.3,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.11
hepatitis c virus,Q21130023,Nucleolar and coiled-body phosphoprotein 1,none,0,0,3.3,0.0,1.0,0.0,23.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
hepatitis c virus,Q83166249,Hepatitis C virus non-structural protein NS4b family,none,0,0,2.0,1.39,2.0,10.0,30.0,41.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.78
hepatitis c virus,Q21116275,Aminoacylase 3,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.63
hepatitis c virus,Q24775067,Hepatitis C virus non-structural protein NS2,none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q24773727,Hepatitis C virus non-structural protein E2/NS1,none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q21113367,HD domain containing 2,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.92
hepatitis c virus,Q24740375,"Hepatitis C virus core protein, N-terminal",none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q24774070,"Hepatitis C virus non-structural 5a, 1B domain",none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q21113051,Family with sequence similarity 241 member A,none,0,0,3.9,0.0,1.0,0.0,23.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
hepatitis c virus,Q21107498,GRAM domain containing 2B,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.84
hepatitis c virus,Q21121289,Solute carrier family 35 member F5,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.17
hepatitis c virus,Q21110259,Family with sequence similarity 174 member A,none,0,0,3.9,0.0,1.0,0.0,23.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
hepatitis c virus,Q24741813,Hepatitis C virus envelope glycoprotein E1,none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q24787586,Hepatitis C virus non-structural protein NS4b,none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q21115942,Pecanex 4,none,0,0,3.3,0.0,1.0,0.0,23.5,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.5
hepatitis c virus,Q24775162,Hepatitis C virus non-structural 5a protein,none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q24721941,"Hepatitis C virus core protein, C-terminal",none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q21495321,FUN14 domain containing 2,none,0,0,2.6,0.0,1.0,5.0,23.5,37.3,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.67
hepatitis c virus,Q24739835,Hepatitis C virus non-structural protein NS4a,none,0,0,2.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
hepatitis c virus,Q21172025,Chromosome 4 open reading frame 3,none,0,0,3.3,0.0,1.0,0.0,23.5,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.82
hepatitis c virus,Q21107525,FUN14 domain containing 2,none,0,0,2.6,0.0,1.0,0.0,23.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.92
hepatitis c virus,Q5731726,Hepatitis C virus stem-loop VII,none,0,0,3.3,0.69,0.0,5.0,0.0,38.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.57
hepatitis c virus,Q5731724,Hepatitis C virus internal ribosome entry site,none,0,0,2.6,0.69,0.0,5.0,0.0,38.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.79
hepatitis c virus,Q5731722,Hepatitis C virus 3'X element,none,0,0,2.6,0.69,0.0,5.0,0.0,38.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.79
hepatitis c virus,Q5731719,Hepatitis C virus cis-acting replication element,none,0,0,2.6,0.69,0.0,5.0,0.0,38.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.79
hepatitis c virus,Q63844817,Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
hepatitis c virus,Q67598138,Hepatitis C Virus P7 Viroporin Cation-selective Channel,none,0,0,2.6,0.0,1.0,2.0,13.6,32.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.04
hepatitis c virus,Q83141240,Hepatitis C virus non-structural protein E2/NS1 family,none,0,0,2.0,0.0,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.38
hepatitis c virus,Q83141375,"Hepatitis C virus non-structural 5a, 1B domain, protein family",none,0,0,2.0,0.0,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.38
hepatitis c virus,Q54461456,"Hepatitis C virus NS5A, 1B domain superfamily",none,0,0,2.0,0.0,1.0,0.0,23.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.88
hepatitis c virus,Q66395283,Hepatitis C Virus(HCV) Heart and Lung Study,none,0,0,3.9,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
hepatitis c virus,Q66047231,Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma,none,0,0,2.6,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
hepatitis c virus,Q115074891,Hepatitis C virus infection in WTC responders,none,0,0,2.6,0.0,1.0,0.0,18.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.12
hepatitis c virus,Q83136874,Hepatitis C virus non-structural protein NS4a family,none,0,0,2.0,0.0,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.38
hepatitis c virus,Q113895362,Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
hepatitis c virus,Q97461970,Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients,none,0,0,3.3,0.0,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.95
hepatitis c virus,Q2082778,Hepacivirus,none,0,0,1.3,2.4,1.0,0.0,25.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.32
spectra,Q483666,spectroscopy,none,0,0,3.1,4.47,2.0,2.0,48.3,45.3,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.12
spectra,Q2870929,amoxicillin/clavulanic acid,none,0,0,0.0,3.4,1.0,4.0,31.6,47.9,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.1
spectra,Q25377588,stellar classification,none,0,0,1.5,3.83,0.0,2.0,0.0,34.2,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.43
spectra,Q108053582,spectral domain optical coherence tomography,none,0,0,4.6,0.0,0.0,3.0,0.0,46.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.21
spectra,Q2308831,spectral method,none,0,0,3.1,2.2,0.0,3.0,0.0,45.6,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.96
spectra,Q7575186,Spectral element method,none,0,0,3.1,1.61,0.0,3.0,0.0,43.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.64
spectra,Q179600,spectral class,none,0,0,1.5,3.74,1.0,2.0,45.8,38.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.98
spectra,Q411202,dimpylate,none,0,0,0.0,3.3,1.0,2.0,39.4,43.1,0.133,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.79
spectra,Q1095535,Čech cohomology,none,0,0,4.6,2.48,3.0,2.0,45.0,42.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.67
spectra,Q212111,spectral line,none,0,0,0.0,3.87,0.0,3.0,0.0,44.4,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.59
spectra,Q1750705,asteroid spectral type,none,0,0,3.1,3.3,0.0,2.0,0.0,32.6,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.0
spectra,Q25991562,Qualcomm Spectra,alias,0,1,3.1,0.0,1.0,0.0,30.3,0.0,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,29.58
spectra,Q2409122,spectral theory,none,0,0,3.1,2.71,1.0,0.0,33.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.18
spectra,Q1142526,Vampyrum spectrum,none,0,0,3.1,3.61,1.0,0.0,40.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.7
spectra,Q907315,decadic absorbance,none,0,0,6.2,3.14,0.0,5.0,0.0,43.4,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.97
spectra,Q899219,spectral luminous efficiency,none,0,0,1.5,2.94,0.0,4.0,0.0,44.8,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.28
spectra,Q2976589,spectral clustering,none,0,0,0.0,2.4,0.0,2.0,0.0,40.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.72
spectra,Q3503315,spectral sequence,none,0,0,6.2,2.2,0.0,3.0,0.0,45.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.65
spectra,Q2360668,mass spectrum,none,0,0,9.2,2.71,1.0,2.0,30.9,46.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.11
spectra,Q83670630,Rosa 'Spectra',alias,0,1,1.5,0.69,1.0,0.0,18.8,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,29.66
spectra,Q332829,absorption line,none,0,0,10.8,3.0,1.0,2.0,35.0,44.2,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,18.32
spectra,Q1245902,spectral music,none,0,0,4.6,2.56,2.0,3.0,45.8,43.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.02
spectra,Q910300,spectral color,none,0,0,9.2,2.94,0.0,5.0,0.0,44.7,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,16.91
spectra,Q7575217,Spectralia,none,0,0,1.5,2.08,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.09
spectra,Q859277,Spectral tarsier,none,0,0,1.5,3.5,2.0,0.0,44.9,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.39
spectra,Q2941175,SPECTRA helmet,none,0,0,1.5,2.2,0.0,3.0,0.0,45.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.11
spectra,Q67522086,spectral analysis,none,0,0,6.2,0.0,0.0,3.0,0.0,45.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.55
spectra,Q20828899,Spectral,none,0,0,0.0,1.1,1.0,0.0,47.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.32
spectra,Q1331626,spectral density,none,0,0,4.6,3.09,0.0,6.0,0.0,37.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.98
spectra,Q17103407,Spectracanthicus,none,0,0,1.5,2.08,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.09
spectra,Q81072410,spectral radiant intensity in terms of wavelength,none,0,0,4.6,0.69,0.0,3.0,0.0,43.3,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.03
spectra,Q81382741,spectral irradiance with respect to wavelength,none,0,0,3.1,0.69,0.0,3.0,0.0,43.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.69
spectra,Q81664734,spectral radiant exitance with respect to wavelength,none,0,0,3.1,0.69,0.0,5.0,0.0,43.2,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.58
spectra,Q1967557,spectral power distribution,none,0,0,6.2,1.95,0.0,3.0,0.0,43.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.5
spectra,Q80372486,spectral radiant energy density in terms of wavelength,none,0,0,3.1,0.0,0.0,3.0,0.0,43.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.84
spectra,Q80237041,spectral radiant energy,none,0,0,0.0,0.0,0.0,3.0,0.0,43.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.15
spectra,Q7575163,Spectra Records,none,0,0,1.5,0.0,1.0,0.0,40.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
spectra,Q7575169,Spectral Database for Organic Compounds,none,0,0,0.0,1.39,2.0,0.0,43.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.73
spectra,Q83387222,spectral luminous efficacy,none,0,0,0.0,1.1,0.0,5.0,0.0,43.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.89
spectra,Q82969329,spectral radiant exposure with respect to wavelength,none,0,0,3.1,0.69,0.0,3.0,0.0,43.3,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.39
spectra,Q50412900,SPLASH,none,0,0,1.5,0.69,1.0,0.0,43.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
spectra,Q101461777,spectral radiant intensity in terms of frequency,none,0,0,4.6,0.69,0.0,3.0,0.0,43.3,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.03
spectra,Q101435187,spectral radiant exposure with respect to frequency,none,0,0,3.1,0.69,0.0,3.0,0.0,43.3,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.39
spectra,Q101435109,spectral irradiance with respect to frequency,none,0,0,3.1,0.69,0.0,5.0,0.0,43.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.88
spectra,Q215380,groupe de musique,none,0,0,1.5,4.06,0.0,4.0,0.0,46.8,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.15
spectra,Q5294,DVD,none,0,0,0.0,4.64,2.0,6.0,35.7,43.1,0.133,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.62
spectra,Q189967,caryotype,none,0,0,0.0,3.95,0.0,3.0,0.0,43.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.13
spectra,Q3733414,Spectra,label,1,0,3.1,0.69,3.0,0.0,46.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,43.02
spectra,Q3127084,hantologie,none,0,0,6.2,2.56,1.0,0.0,20.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.68
spectra,Q6149551,Spectral Force 3: Innocent Rage,none,0,0,0.0,1.61,1.0,0.0,33.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.94
spectra,Q998297,Spectravideo SVI-728,none,0,0,0.0,2.4,1.0,3.0,40.2,45.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.57
spectra,Q3492866,Spectral vs. Generation,none,0,0,0.0,0.69,1.0,0.0,33.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.48
spectra,Q12336619,Spectral Display,none,0,0,0.0,1.39,1.0,0.0,33.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.82
spectra,Q3753578,Spectracanthicus murinus,none,0,0,0.0,2.4,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.4
spectra,Q3492864,Spectral,none,0,0,0.0,0.0,2.0,0.0,45.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.06
spectra,Q21325281,Spectracanthicus zuanoni,none,0,0,0.0,1.61,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.01
spectra,Q21325285,Spectracanthicus tocantinensis,none,0,0,0.0,1.61,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.01
spectra,Q21325289,Spectracanthicus immaculatus,none,0,0,0.0,1.61,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.01
spectra,Q110990894,Spectra Musique,none,0,0,1.5,0.0,1.0,0.0,40.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
spectra,Q102356118,Spectra*Paris,none,0,0,1.5,0.69,1.0,0.0,33.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.32
spectra,Q2069518,SPECTRE,alias,0,1,1.5,3.14,1.0,0.0,28.3,0.0,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,37.47
spectra,Q118141087,Spectra,label,1,0,3.1,0.0,2.0,0.0,44.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,38.2
cone,Q25851,European Rabbit,none,0,0,1.5,4.58,1.0,3.0,40.5,41.4,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.9
cone,Q226134,NGC 2264,none,0,0,6.2,3.64,6.0,0.0,41.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.92
cone,Q1224951,cone beam computed tomography,none,0,0,1.5,2.64,0.0,3.0,0.0,45.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
cone,Q9394,rabbit,none,0,0,3.1,4.97,2.0,5.0,49.3,47.3,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.4
cone,Q42344,cone,label,1,0,1.5,4.66,0.0,8.0,0.0,42.7,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,60.12
cone,Q22710,cone,label,1,0,1.5,4.25,2.0,5.0,35.6,47.5,0.154,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,55.46
cone,Q47224,Conegliano,none,0,0,0.0,4.26,1.0,0.0,34.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.27
cone,Q147298,cone cell,none,0,0,3.1,3.89,1.0,7.0,41.9,42.5,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.06
cone,Q312455,Conejos County,none,0,0,1.5,3.95,1.0,0.0,31.6,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.14
cone,Q8453,Giovanni Battista Cima da Conegliano,none,0,0,1.5,3.33,1.0,0.0,43.6,0.0,0.062,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.93
cone,Q636113,Cornelis Janssens van Ceulen,none,0,0,0.0,2.77,1.0,0.0,43.6,0.0,0.014,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.66
cone,Q159466,Leucadendron,none,0,0,1.5,3.14,1.0,0.0,40.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.62
cone,Q37299485,Cone,label,1,0,1.5,1.1,1.0,0.0,40.5,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,35.9
cone,Q2653441,strobilus,alias,0,1,3.1,2.89,0.0,2.0,0.0,29.3,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,42.23
cone,Q628201,Coney Island,none,0,0,1.5,3.89,3.0,0.0,47.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.67
cone,Q18553315,cone-rod dystrophy,none,0,0,9.2,0.0,1.0,5.0,43.5,45.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.18
cone,Q181055,hot dog,none,0,0,3.1,4.5,0.0,9.0,0.0,38.6,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.15
cone,Q1248512,Conesa,none,0,0,1.5,3.58,1.0,0.0,28.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.72
cone,Q487716,Conecuh County,none,0,0,1.5,3.95,1.0,0.0,31.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.14
cone,Q147270,cone dystrophy,none,0,0,6.2,2.4,2.0,2.0,47.1,40.6,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.93
cone,Q111329771,Cone biopsy,none,0,0,1.5,0.0,1.0,0.0,45.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.1
cone,Q2614974,Coney Island-Stilwell Avenue,none,0,0,0.0,2.4,4.0,0.0,42.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.82
cone,Q13381446,Triatominae,none,0,0,1.5,3.09,1.0,0.0,40.5,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
cone,Q1124882,Veiled chameleon,none,0,0,1.5,3.56,1.0,0.0,40.5,0.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.29
cone,Q57910892,Conel M. O'D. Alexander,none,0,0,1.5,0.0,1.0,0.0,43.6,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.94
cone,Q4258250,Conescharellina,none,0,0,1.5,1.79,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.95
cone,Q493171,cone,label,1,0,3.1,1.61,0.0,3.0,0.0,48.2,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,43.8
cone,Q1145450,Conepatus,none,0,0,1.5,3.4,1.0,0.0,40.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.25
cone,Q5891900,Hans Joachim Conert,none,0,0,0.0,1.39,1.0,0.0,43.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.93
cone,Q2682724,Coneto de Comonfort Municipality,none,0,0,4.6,2.48,1.0,0.0,31.6,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.1
cone,Q1635267,cone,label,1,0,1.5,2.3,1.0,3.0,14.3,46.2,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,43.56
cone,Q37322077,Conesa,none,0,0,0.0,0.69,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.55
cone,Q3686494,Conegliano Calcio,none,0,0,0.0,0.69,1.0,0.0,24.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.39
cone,Q764020,Mexican burrowing toad,none,0,0,1.5,3.5,1.0,0.0,40.3,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.8
cone,Q668030,Volcano rabbit,none,0,0,1.5,3.69,1.0,0.0,40.5,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.56
cone,Q1671747,conical hill,alias,0,1,4.6,1.95,0.0,3.0,0.0,44.7,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,45.64
cone,Q5159528,Conestoga High School,none,0,0,1.5,1.1,1.0,0.0,43.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.63
cone,Q2217981,Coney Weston,none,0,0,1.5,2.4,2.0,0.0,44.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.09
cone,Q73364583,Council for Nutritional and Environmental Medicine,none,0,0,1.5,0.0,1.0,0.0,42.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.07
cone,Q6967778,Conehead termite,none,0,0,1.5,2.08,1.0,0.0,40.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.09
cone,Q5159535,Conestoga River,none,0,0,1.5,1.95,1.0,0.0,28.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.9
cone,Q3010602,Cône,none,0,0,1.5,1.61,1.0,0.0,28.2,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.73
cone,Q3691494,Coneuplecta,none,0,0,1.5,1.79,1.0,0.0,40.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.95
cone,Q43682764,cone snail,none,0,0,4.6,1.39,1.0,0.0,43.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.96
cone,Q85753795,Cone,label,1,0,3.1,1.39,1.0,0.0,43.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,41.73
cone,Q490248,Conepatus chinga,none,0,0,1.5,3.53,1.0,0.0,40.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.01
cone,Q5159523,Conestoga College,none,0,0,1.5,1.79,1.0,0.0,35.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.39
cone,Q18553394,blue cone monochromacy,none,0,0,1.5,1.61,2.0,7.0,45.5,37.8,0.105,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.52
cone,Q1792069,Cônego Marinho,none,0,0,1.5,3.26,1.0,0.0,29.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.57
cone,Q1413947,Araneus,none,0,0,1.5,3.58,1.0,0.0,40.5,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.44
cone,Q140435,Conidae,none,0,0,0.0,3.5,1.0,0.0,40.5,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.81
cone,Q559423,cône de croissance,none,0,0,0.0,2.2,1.0,2.0,31.2,36.7,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.45
cone,Q7569,enfant,none,0,0,1.5,5.44,2.0,8.0,40.6,35.7,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.26
cone,Q1368970,cône volcanique,none,0,0,0.0,3.43,0.0,5.0,0.0,41.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.05
cone,Q1806785,cône de scories,none,0,0,1.5,3.4,0.0,3.0,0.0,45.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.21
cone,Q1137903,cône de lumière,none,0,0,4.6,3.4,0.0,3.0,0.0,43.9,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.39
cone,Q465088,cône de déjection,none,0,0,3.1,3.83,0.0,5.0,0.0,45.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.47
cone,Q1104153,chanoine,none,0,0,1.5,3.93,3.0,3.0,46.0,46.4,0.105,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.16
cone,Q236118,Cône Sud,none,0,0,1.5,3.97,1.0,0.0,42.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
cone,Q998,nourrisson,none,0,0,0.0,4.86,2.0,4.0,39.9,47.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.87
cone,Q792607,cône axonique,none,0,0,4.6,2.89,1.0,2.0,31.2,35.4,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.58
cone,Q474330,Conficker,none,0,0,0.0,3.5,1.0,0.0,36.6,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.46
cone,Q737406,Cône rituel en or,none,0,0,1.5,2.83,0.0,11.0,0.0,34.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.14
cone,Q79803,Cavia porcellus,none,0,0,0.0,4.68,2.0,0.0,46.4,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.0
cone,Q2033177,Coneysthorpe,none,0,0,0.0,2.3,2.0,0.0,44.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.2
cone,Q1142381,cône adventif,none,0,0,0.0,3.0,0.0,3.0,0.0,45.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.16
cone,Q9081,connaissance,none,0,0,0.0,5.26,1.0,3.0,33.9,48.9,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.16
cone,Q5159441,Cone,label,1,0,1.5,1.61,1.0,0.0,48.0,0.0,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,36.11
cone,Q688635,Conepatus semistriatus,none,0,0,0.0,3.56,1.0,0.0,40.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.48
cone,Q1779300,connectivité,none,0,0,3.1,2.83,1.0,4.0,43.5,46.5,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.66
cone,Q5159518,Conessine,none,0,0,0.0,2.2,1.0,4.0,39.4,43.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.54
cone,Q934487,Conepatus leuconotus,none,0,0,0.0,3.43,1.0,0.0,40.5,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.78
cone,Q28163089,Conestoga,none,0,0,0.0,1.1,2.0,0.0,43.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.08
subshift,Q106637555,SUBSHIFT,label,1,0,3.1,0.0,1.0,0.0,43.6,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,36.19
subshift,Q7631990,subshift of finite type,none,0,0,6.2,0.69,0.0,3.0,0.0,53.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.96
turing degree,Q1527413,Turing degree,label,1,0,7.7,2.3,1.0,0.0,29.6,0.0,0.286,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,56.08
friction,Q82580,friction,label,1,0,4.6,4.5,0.0,5.0,0.0,46.7,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,61.53
friction,Q51606,approximant consonant,none,0,0,1.8,3.89,1.0,2.0,21.2,35.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.14
friction,Q1441169,Frictional Games,none,0,0,0.9,2.94,1.0,0.0,29.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.67
friction,Q1932524,coefficient of friction,none,0,0,8.3,2.94,1.0,2.0,37.6,29.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.5
friction,Q583827,friction drum,none,0,0,4.6,1.95,1.0,2.0,21.5,31.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.94
friction,Q5135523,closure,none,0,0,4.6,2.89,0.0,6.0,0.0,48.4,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.4
friction,Q5503421,Friction,label,1,0,0.9,1.1,1.0,0.0,23.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,33.65
friction,Q5205325,Friction,label,1,0,1.8,0.69,1.0,0.0,36.1,0.0,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,33.07
friction,Q18830,plain bearing,none,0,0,5.5,3.47,0.0,4.0,0.0,48.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.62
friction,Q9097454,rummelpott,none,0,0,0.9,2.08,0.0,2.0,0.0,47.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.72
friction,Q5503427,friction idiophone,none,0,0,2.8,0.69,1.0,3.0,21.5,39.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.28
friction,Q2068127,friction stir welding,none,0,0,2.8,2.94,1.0,3.0,31.4,48.4,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.58
friction,Q2463151,interference fit,none,0,0,3.7,2.64,0.0,2.0,0.0,39.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
friction,Q2795254,frictional unemployment,none,0,0,4.6,2.94,0.0,3.0,0.0,44.8,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.89
friction,Q107596312,friction hitch knot,none,0,0,5.5,1.39,0.0,2.0,0.0,35.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.78
friction,Q588936,friction welding,none,0,0,1.8,3.0,1.0,3.0,31.4,48.4,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.0
friction,Q55724342,friction drums with tied stick,none,0,0,3.7,0.0,1.0,2.0,21.5,29.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.85
friction,Q55722819,friction vessels,none,0,0,1.8,0.0,1.0,3.0,21.5,37.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
friction,Q513595,Friction drive,none,0,0,1.8,2.56,0.0,3.0,0.0,48.4,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.67
friction,Q306352,friction drive car,none,0,0,2.8,1.61,1.0,0.0,26.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.17
friction,Q16856760,Skin friction drag,none,0,0,1.8,1.61,0.0,11.0,0.0,52.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.03
friction,Q55722217,friction sticks,none,0,0,1.8,0.0,1.0,3.0,21.5,37.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
friction,Q55724322,friction drums with inserted stick,none,0,0,3.7,0.0,1.0,2.0,21.5,29.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.85
friction,Q55722887,friction sheet,none,0,0,1.8,0.0,1.0,3.0,21.5,37.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.31
friction,Q55722796,friction plaques,none,0,0,1.8,0.0,1.0,3.0,21.5,37.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
friction,Q66568864,friction ridge,none,0,0,2.8,2.08,1.0,2.0,39.1,10.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.82
friction,Q5503424,friction blister,none,0,0,0.9,1.79,0.0,2.0,0.0,33.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.46
friction,Q55724319,friction drums with stick,none,0,0,3.7,0.0,1.0,2.0,21.5,33.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.88
friction,Q55724298,friction drums with cord,none,0,0,2.8,0.0,1.0,2.0,21.5,33.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.78
friction,Q3457815,friction loss,none,0,0,4.6,2.48,0.0,2.0,0.0,22.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.13
friction,Q5503423,Friction burn,none,0,0,1.8,1.79,0.0,2.0,0.0,33.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.56
friction,Q91005629,kinetic friction force,none,0,0,4.6,0.0,0.0,7.0,0.0,51.7,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.32
friction,Q478432,friction drilling,none,0,0,6.4,2.08,1.0,0.0,24.9,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.79
friction,Q1464899,Friction motor,none,0,0,2.8,1.79,0.0,3.0,0.0,38.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.3
friction,Q5503434,friction tape,none,0,0,0.9,1.1,0.0,2.0,0.0,22.6,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.03
friction,Q55722842,friction vessels with cord,none,0,0,2.8,0.0,1.0,2.0,21.5,24.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.72
friction,Q55722838,friction vessels with stick,none,0,0,3.7,0.0,1.0,2.0,21.5,24.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.82
friction,Q55724333,friction drums with free stick,none,0,0,3.7,0.0,1.0,2.0,21.5,41.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.95
friction,Q1413596,friction,label,1,0,0.9,1.61,2.0,3.0,42.4,41.7,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,43.46
friction,Q4419098,friction de glissement,none,0,0,0.9,2.2,1.0,6.0,21.7,52.4,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.74
friction,Q473991,friction de Coulomb,none,0,0,0.9,1.79,1.0,0.0,19.0,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.99
friction,Q1268968,Friction dynamique,none,0,0,4.6,2.48,1.0,5.0,24.4,52.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.71
friction,Q130247373,FRICTION,label,1,0,0.9,0.0,1.0,0.0,21.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.23
friction,Q5503419,Friction Groove,none,0,0,0.9,0.69,1.0,0.0,23.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.48
uncertainty,Q13649246,uncertainty,label,1,0,3.7,3.93,4.0,8.0,46.8,48.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,71.4
uncertainty,Q1403517,measurement uncertainty,alias,0,1,2.8,3.37,2.0,3.0,40.6,45.3,0.333,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,47.0
uncertainty,Q44746,uncertainty principle,none,0,0,0.9,4.36,1.0,5.0,24.4,49.4,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.18
uncertainty,Q7882499,uncertainty quantification,none,0,0,2.8,0.69,0.0,3.0,0.0,48.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.34
uncertainty,Q15747751,Uncertainty,label,1,0,0.0,1.1,1.0,0.0,17.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,30.77
uncertainty,Q27722933,Uncertainty in artificial intelligence : proceedings of the ... conference. Conference on Uncertainty in Artificial Intelligence,none,0,0,3.7,0.0,1.0,0.0,16.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.86
uncertainty,Q29205,uncertainty analysis,none,0,0,8.3,1.39,0.0,5.0,0.0,51.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.01
uncertainty,Q63366162,Uncertainty reduction in Models For Understanding deveLopment Applications (UMFULA),none,0,0,1.8,0.0,2.0,0.0,35.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.16
uncertainty,Q103854642,Uncertainty & Destiny,none,0,0,0.0,0.0,1.0,0.0,21.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.01
uncertainty,Q87529795,⯑,none,0,0,0.0,0.0,1.0,0.0,37.0,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.37
uncertainty,Q111026956,Uncertainty Quantification and Assimilation for Efficient Coastal Ocean Forecasting,none,0,0,1.8,0.0,1.0,0.0,24.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.24
uncertainty,Q15514847,Uncertainty avoidance,none,0,0,2.8,1.61,0.0,3.0,0.0,46.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.28
uncertainty,Q85811899,uncertainty management theory,none,0,0,4.6,1.1,0.0,2.0,0.0,21.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.42
uncertainty,Q26237246,Uncertainty in the risk assessment of environmental and occupational hazards,none,0,0,3.7,0.0,1.0,0.0,31.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.52
uncertainty,Q130485222,Uncertainty,label,1,0,0.9,0.0,1.0,0.0,23.5,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.27
uncertainty,Q6277491,uncertainty parameter,none,0,0,3.7,2.3,1.0,0.0,33.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.19
uncertainty,Q7882500,uncertainty reduction theory,none,0,0,3.7,1.79,1.0,0.0,35.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.96
uncertainty,Q7882493,Uncertainty coefficient,none,0,0,2.8,1.1,1.0,0.0,32.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.97
uncertainty,Q4004515,Uncertainty Principle,none,0,0,0.0,0.69,1.0,0.0,23.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.38
uncertainty,Q75720733,Conference on Uncertainty in Artificial Intelligence,none,0,0,1.8,0.0,1.0,0.0,32.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.33
microslip,Q13851115,micro-slip,alias,0,1,3.7,0.69,1.0,0.0,44.7,0.0,1.0,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,39.19
stochastic process,Q176737,stochastic process,label,1,0,5.5,3.89,2.0,5.0,26.6,47.4,0.4,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,66.71
maximum entropy,Q106416338,maximum entropy,label,1,0,2.8,0.0,0.0,3.0,0.0,45.2,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,37.66
maximum entropy,Q6795892,Maximum entropy probability distribution,none,0,0,5.5,1.39,1.0,5.0,15.0,51.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.66
maximum entropy,Q117217567,Maximum Entropy Modeling,none,0,0,2.8,0.0,1.0,0.0,23.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.33
simulation,Q1610017,simulation video game,none,0,0,0.0,3.61,1.0,9.0,20.8,48.1,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.35
simulation,Q45045,simulation,label,1,0,7.3,4.08,0.0,12.0,0.0,45.1,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,79.9
simulation,Q1529437,tactical role-playing game,none,0,0,0.0,3.09,1.0,4.0,20.8,39.9,0.133,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
simulation,Q11121294,simulation software,none,0,0,0.9,2.08,1.0,4.0,15.0,48.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.87
simulation,Q1137176,simulation game,none,0,0,0.9,1.39,0.0,6.0,0.0,47.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.78
simulation,Q488231,malingering,none,0,0,1.8,3.33,2.0,2.0,36.8,36.9,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.83
simulation,Q2252900,diving,alias,0,1,1.8,3.04,0.0,3.0,0.0,46.9,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,40.39
simulation,Q111635371,flopping,alias,0,1,2.8,0.0,1.0,5.0,22.8,48.2,0.333,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,33.65
simulation,Q7521343,Simulations Canada,none,0,0,0.0,1.39,2.0,0.0,30.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
simulation,Q7521336,simulation language,none,0,0,6.4,2.2,0.0,2.0,0.0,37.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.81
simulation,Q174907,SPICE,none,0,0,0.9,3.04,2.0,0.0,32.2,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
simulation,Q20820015,simulation model,none,0,0,5.5,0.69,0.0,3.0,0.0,47.6,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.13
simulation,Q114813752,Simulation of Geophysical Fluid Flow Under Microgravity-1,none,0,0,0.9,0.0,1.0,0.0,22.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.12
simulation,Q114813070,Simulation of Geophysical Fluid Flow Under Microgravity - 2,none,0,0,0.9,0.0,1.0,0.0,22.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.12
simulation,Q113994723,Simulation Councils Inc (SCI),none,0,0,0.0,0.0,1.0,0.0,26.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.06
simulation,Q2742884,simulation hypothesis,none,0,0,1.8,3.4,1.0,3.0,33.8,45.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.21
simulation,Q7521318,Simulation Pro Yakyū,none,0,0,0.0,0.69,1.0,0.0,24.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.89
simulation,Q15847637,Simulation of Urban MObility,none,0,0,1.8,1.95,1.0,0.0,26.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.24
simulation,Q28006967,simulation supervisor,none,0,0,0.0,0.0,0.0,4.0,0.0,47.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.78
simulation,Q105696305,"Simulation, Modeling, and Programming for Autonomous Robots",none,0,0,2.8,0.0,1.0,0.0,32.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.43
simulation,Q60052868,Simulation Theory World Tour,none,0,0,0.0,1.39,1.0,0.0,34.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.83
simulation,Q111026262,Simulation of Magnetic Phenomena at Realistic Interfaces,none,0,0,1.8,0.0,1.0,0.0,24.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.24
simulation,Q105698984,Simulationstechnik,none,0,0,0.0,0.0,1.0,0.0,32.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.12
simulation,Q106034852,"Simulation and Synthesis in Medical Imaging - Second International Workshop, SASHIMI 2017, Held in Conjunction with MICCAI 2017, Québec City, QC, Canada, September 10, 2017",none,0,0,3.7,0.0,1.0,0.0,6.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.27
simulation,Q5157537,computer experiment,none,0,0,2.8,1.39,0.0,3.0,0.0,47.4,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.18
simulation,Q64691193,Simulation-to-Flight 1,none,0,0,0.0,1.1,1.0,0.0,18.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.53
simulation,Q925667,simulation informatique,none,0,0,0.0,3.74,1.0,4.0,24.0,49.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.7
simulation,Q232207,méthode de Monte-Carlo,none,0,0,0.0,4.01,1.0,6.0,36.7,48.3,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.02
simulation,Q1755722,Simulation de la turbulence,none,0,0,1.8,2.48,1.0,0.0,43.4,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.88
simulation,Q1199309,jeu de simulation de vie,none,0,0,0.0,3.3,1.0,3.0,20.8,28.3,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.18
simulation,Q1339223,simulation de drague,none,0,0,0.0,3.04,1.0,6.0,20.8,37.8,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.86
simulation,Q1501543,jeu de guerre,none,0,0,0.0,3.37,1.0,2.0,14.8,40.3,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.7
simulation,Q1417032,sim racing,none,0,0,0.0,2.94,2.0,7.0,30.5,48.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.47
simulation,Q578868,simulation de véhicule,none,0,0,0.0,2.83,1.0,4.0,20.8,29.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.06
simulation,Q3775539,jeu vidéo de simulation gouvernementale,none,0,0,0.0,2.83,1.0,2.0,20.8,14.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.24
simulation,Q221181,simulation ferroviaire,none,0,0,0.0,2.77,1.0,2.0,20.8,34.3,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.53
simulation,Q4451239,simulation de tanks,none,0,0,0.0,1.79,1.0,3.0,20.8,33.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.98
simulation,Q71474253,jeu vidéo de chasse,none,0,0,0.0,0.0,1.0,7.0,20.8,42.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.05
simulation,Q2508200,simulation militaire,none,0,0,5.5,2.56,0.0,8.0,0.0,44.7,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.9
simulation,Q25303631,Simulation de cerveau,none,0,0,0.0,2.2,0.0,2.0,0.0,48.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.69
simulation,Q195818,simulation médicale,none,0,0,0.0,2.2,0.0,4.0,0.0,49.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.75
simulation,Q5431499,pseudocide,none,0,0,6.4,2.4,1.0,2.0,20.8,31.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.11
simulation,Q574814,Simulation à événements discrets,none,0,0,0.0,2.77,0.0,9.0,0.0,44.6,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.14
simulation,Q2552748,waterboarding,none,0,0,0.0,3.56,2.0,4.0,28.9,36.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.36
simulation,Q290036,simulation réseau,none,0,0,0.0,2.08,0.0,4.0,0.0,49.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.83
simulation,Q465266,simulation de foule,none,0,0,1.8,2.56,0.0,4.0,0.0,49.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.28
simulation,Q7300799,simulation en temps réel,none,0,0,0.9,1.95,0.0,2.0,0.0,48.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.66
simulation,Q838129,simulation des procédés,none,0,0,1.8,2.64,0.0,4.0,0.0,49.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.31
simulation,Q1434937,simulation de fluide,none,0,0,0.0,2.4,0.0,7.0,0.0,46.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.77
simulation,Q7521300,simulation de grossesse,none,0,0,0.0,0.69,0.0,2.0,0.0,42.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.89
simulation,Q520470,simulation à N corps,none,0,0,4.6,1.79,0.0,4.0,0.0,49.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.19
simulation,Q1227572,simulation numérique directe,none,0,0,0.9,2.56,1.0,2.0,20.0,31.4,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
simulation,Q4638885,Simulation 4D de la construction,none,0,0,1.8,1.39,1.0,0.0,26.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.96
simulation,Q110068411,jeu vidéo de blackjack,none,0,0,0.0,0.0,1.0,5.0,20.8,36.3,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.96
bayesian model,Q133280464,Bayesian Models of Cognition,none,0,0,1.9,0.0,1.0,0.0,25.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.27
entropy,Q204570,information entropy,alias,0,1,3.1,3.87,2.0,6.0,23.3,43.2,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,52.3
entropy,Q45003,entropy,label,1,0,2.5,4.61,0.0,12.0,0.0,48.6,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,66.8
entropy,Q5380792,entropy,label,1,0,1.2,2.08,0.0,10.0,0.0,44.3,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,50.57
entropy,Q1345239,entropy coding,none,0,0,2.5,2.71,0.0,6.0,0.0,48.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.81
entropy,Q12727673,entropy,label,1,0,1.2,2.48,0.0,5.0,0.0,33.8,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,44.49
entropy,Q5380791,Entropy,label,1,0,0.6,0.69,1.0,0.0,22.8,0.0,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.13
entropy,Q112147176,Entropy,label,1,0,0.6,0.0,1.0,0.0,17.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,28.24
entropy,Q16267889,Entropy,label,1,0,1.2,0.69,1.0,0.0,17.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.87
entropy,Q115918930,Entropy,label,1,0,1.2,0.0,1.0,0.0,21.6,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,30.18
entropy,Q23003188,USS Turquoise,alias,0,1,3.1,1.1,3.0,0.0,22.2,0.0,0.154,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,35.09
entropy,Q97159565,Entropy,label,1,0,1.9,0.69,1.0,0.0,27.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.92
entropy,Q5380793,Entropy,label,1,0,1.2,0.0,2.0,0.0,24.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.24
entropy,Q70026841,Entropy : Zero,none,0,0,0.6,1.1,2.0,0.0,24.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.63
entropy,Q2555655,Minkowski–Bouligand dimension,none,0,0,3.1,2.71,1.0,0.0,31.2,0.0,0.133,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.57
entropy,Q109319904,entropy unit,none,0,0,1.2,0.69,2.0,0.0,36.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.79
entropy,Q114834789,Entropy: Zero 2,none,0,0,1.2,1.39,2.0,0.0,24.0,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.87
entropy,Q1000031,entropy of mixing,none,0,0,3.1,2.2,1.0,0.0,20.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.8
entropy,Q367131,entropy of activation,none,0,0,1.2,1.95,0.0,5.0,0.0,33.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.72
entropy,Q22682016,Entropy-supplying system calls,none,0,0,0.6,0.69,0.0,3.0,0.0,31.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.14
entropy,Q5867823,history of entropy,none,0,0,2.5,1.95,1.0,0.0,20.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.94
entropy,Q5380803,entropy in thermodynamics and information theory,none,0,0,3.1,1.1,2.0,0.0,31.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.16
entropy,Q5380796,entropy in order and disorder,none,0,0,3.7,0.69,0.0,2.0,0.0,32.7,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.92
entropy,Q79970477,RFC 8662: Entropy Label for Source Packet Routing in Networking (SPRING) Tunnels,none,0,0,1.9,0.0,1.0,0.0,17.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.7
entropy,Q46404925,Entropy gain due to water release upon ligand binding.,none,0,0,1.9,0.0,1.0,0.0,21.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.23
entropy,Q114568668,Entropy Stereo Recordings,none,0,0,0.6,0.0,1.0,0.0,25.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.79
entropy,Q98918494,Entropy for Quantum Information Science,none,0,0,1.2,0.0,1.0,0.0,24.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.53
entropy,Q1957501,Entropy,label,1,0,1.9,1.1,2.0,0.0,37.2,0.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,37.44
entropy,Q5380787,Entropy,label,1,0,2.5,0.69,1.0,0.0,19.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,36.6
nonparametric statistic,Q1097688,non-parametric statistics,none,0,0,2.5,3.26,2.0,0.0,34.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.03
earthquake,Q7944,earthquake,label,1,0,4.9,5.44,0.0,13.0,0.0,41.3,0.222,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,77.55
earthquake,Q575370,San Jose Earthquakes,none,0,0,1.0,3.69,1.0,0.0,16.0,0.0,0.125,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.34
earthquake,Q99225387,earthquake damage,none,0,0,1.9,0.69,0.0,2.0,0.0,28.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.1
earthquake,Q27243340,earthquake.usgs.gov,none,0,0,1.0,0.0,2.0,0.0,35.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.62
earthquake,Q211386,1906 San Francisco earthquake,none,0,0,2.9,3.93,1.0,0.0,33.9,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.1
earthquake,Q909789,earthquake engineering,none,0,0,1.0,3.71,4.0,0.0,49.7,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.39
earthquake,Q1345719,John Tenta,alias,0,1,1.0,2.83,1.0,0.0,35.0,0.0,0.25,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,33.48
earthquake,Q107410,hypocenter,none,0,0,2.9,4.16,1.0,2.0,17.5,34.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.03
earthquake,Q4385952,Earthquake,label,1,0,0.0,1.39,2.0,0.0,35.6,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.33
earthquake,Q22828674,Earthquake,label,1,0,0.0,1.1,1.0,0.0,46.8,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.43
earthquake,Q825301,Earthquake,label,1,0,0.0,1.61,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.95
earthquake,Q489523,earthquake swarm,none,0,0,4.9,2.83,0.0,6.0,0.0,47.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.72
earthquake,Q112158455,earthquake doublet,none,0,0,2.9,0.0,0.0,8.0,0.0,46.8,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.87
earthquake,Q500062,magnitude,none,0,0,2.9,3.47,0.0,5.0,0.0,46.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.6
earthquake,Q61826745,Earthquake,label,1,0,1.9,0.0,1.0,0.0,25.5,0.0,0.4,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.99
earthquake,Q22998,Earthquake,label,1,0,1.0,1.1,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,33.82
earthquake,Q5327254,Earthquake,label,1,0,1.0,1.79,1.0,0.0,35.0,0.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,35.52
earthquake,Q14841262,Earthquake,label,1,0,1.9,1.61,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,38.77
earthquake,Q4966511,"Earthquake Research Institute, University of Tokyo",none,0,0,3.9,1.79,1.0,0.0,27.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.63
earthquake,Q112083274,Earthquake,label,1,0,1.0,0.0,2.0,0.0,29.6,0.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,30.23
earthquake,Q606654,earthquake prediction,none,0,0,1.0,3.09,0.0,2.0,0.0,43.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.26
earthquake,Q5327255,Earthquake Baroque,none,0,0,2.9,1.61,1.0,3.0,25.1,30.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.39
earthquake,Q26156773,Earthquake,label,1,0,0.0,0.0,3.0,0.0,34.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,30.75
earthquake,Q5327252,Earthquake,label,1,0,0.0,0.0,0.0,3.0,0.0,35.6,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,27.88
earthquake,Q556991,anchor plate,none,0,0,1.9,3.09,0.0,4.0,0.0,42.1,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.21
earthquake,Q16004619,2014 Iquique earthquake,none,0,0,1.9,3.04,2.0,0.0,40.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.86
earthquake,Q111014585,West Pasaman earthquake 2022,none,0,0,1.0,2.94,3.0,0.0,47.9,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.02
earthquake,Q1772541,earthquake in New Zealand,none,0,0,1.9,1.1,1.0,5.0,29.9,46.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.85
earthquake,Q2309047,list of earthquakes in 2006,none,0,0,1.9,1.61,1.0,0.0,26.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.2
earthquake,Q110845266,earthquake engineer,none,0,0,0.0,0.0,2.0,3.0,37.5,40.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.1
earthquake,Q2260901,earthquake bomb,none,0,0,0.0,2.3,1.0,3.0,38.4,30.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
earthquake,Q5327282,earthquake warning system,none,0,0,5.8,2.64,1.0,2.0,16.7,39.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.79
earthquake,Q3046470,PayPal Park,none,0,0,1.0,3.0,1.0,0.0,17.9,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.64
earthquake,Q2656128,seismic analysis,none,0,0,4.9,1.95,0.0,2.0,0.0,43.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.35
earthquake,Q11424735,archaeoseismology,none,0,0,1.0,1.95,1.0,0.0,19.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.13
earthquake,Q132398896,Earthquake,label,1,0,0.0,2.08,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.83
earthquake,Q10478908,Earthquake,label,1,0,1.0,0.69,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.19
earthquake,Q5327251,Earthquake,label,1,0,1.0,0.69,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.19
earthquake,Q21912696,Earthquake Springs Drain,none,0,0,0.0,1.1,1.0,0.0,20.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.55
earthquake,Q1348954,séisme de 365 en Crète,none,0,0,6.8,3.22,3.0,0.0,47.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.84
earthquake,Q2176489,liste de séismes survenus en 2004,none,0,0,1.0,1.39,1.0,0.0,26.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.92
stochastic process,Q176737,stochastic process,label,1,0,5.8,3.89,2.0,5.0,27.0,47.1,0.4,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,67.68
information theory,Q131222,information theory,label,1,0,6.8,4.36,2.0,2.0,32.5,36.8,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,67.6
information theory,Q27473350,"Information Theory, 2005. ISIT 2005. Proceedings. International Symposium on",none,0,0,2.9,0.0,1.0,0.0,34.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.64
information theory,Q27473251,"Information Theory, 2003. Proceedings. IEEE International Symposium on",none,0,0,2.9,0.0,1.0,0.0,34.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.64
information theory,Q105692978,Information Theory Workshop,none,0,0,2.9,0.0,1.0,0.0,32.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.62
information theory,Q102791090,"Information Theory, 2020. Proceedings. IEEE International Symposium on",none,0,0,2.9,0.0,1.0,0.0,34.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.64
information theory,Q5868014,history of information theory,none,0,0,2.9,1.1,1.0,0.0,27.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.12
information theory,Q105701747,Information Theory and Applications Workshop,none,0,0,3.9,0.0,1.0,0.0,32.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.78
maximum entropy,Q106416338,maximum entropy,label,1,0,4.9,0.0,0.0,3.0,0.0,44.7,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,43.96
maximum entropy,Q6795892,Maximum entropy probability distribution,none,0,0,6.8,1.39,1.0,5.0,52.4,50.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,16.58
maximum entropy,Q117217567,Maximum Entropy Modeling,none,0,0,1.9,0.0,1.0,0.0,22.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
high temperature,Q28128222,hot,alias,0,1,2.6,0.0,2.0,0.0,35.6,0.0,0.25,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,28.53
high temperature,Q846667,high temperature superconductor,none,0,0,4.3,3.5,0.0,2.0,0.0,39.8,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.59
high temperature,Q637345,superalloy,none,0,0,2.6,3.33,0.0,4.0,0.0,38.2,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
high temperature,Q21111681,HtrA serine peptidase 2,none,0,0,4.3,0.0,1.0,0.0,26.4,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.74
high temperature,Q21981437,HtrA serine peptidase 2,none,0,0,4.3,0.0,1.0,5.0,26.4,40.1,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.06
high temperature,Q4103521,high-temperature coal tar pitch,none,0,0,0.0,1.1,1.0,0.0,23.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.59
high temperature,Q29819537,HTRA2-related serine protease Dmel_CG8464,none,0,0,3.4,0.0,1.0,0.0,26.4,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.71
high temperature,Q29666659,hid-1,none,0,0,2.6,0.0,1.0,0.0,17.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.55
high temperature,Q21103357,HtrA serine peptidase 1,none,0,0,3.4,0.0,1.0,0.0,26.4,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.83
high temperature,Q59295765,High temperature nitriding,none,0,0,6.8,0.0,0.0,4.0,0.0,40.8,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.93
high temperature,Q21981438,HtrA serine peptidase 1,none,0,0,3.4,0.0,1.0,0.0,26.4,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.92
high temperature,Q21103353,HtrA serine peptidase 3,none,0,0,1.7,0.0,1.0,0.0,26.4,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.97
high temperature,Q1493450,High temperature corrosion,none,0,0,2.6,2.2,0.0,3.0,0.0,42.8,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.32
high temperature,Q59296293,high temperature nitrocarburizing,none,0,0,7.7,0.0,0.0,3.0,0.0,35.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.32
high temperature,Q62181398,"High-temperature-induced dauer-formation protein, putative",none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.46
high temperature,Q29832825,HtrA serine peptidase 1a,none,0,0,2.6,0.0,1.0,0.0,26.4,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.0
high temperature,Q21103352,HtrA serine peptidase 4,none,0,0,2.6,0.0,1.0,0.0,26.4,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.14
high temperature,Q21981436,HtrA serine peptidase 3,none,0,0,1.7,0.0,1.0,5.0,26.4,40.1,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.19
high temperature,Q1408813,high-temperature electrolysis,none,0,0,0.9,2.3,0.0,3.0,0.0,39.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.29
high temperature,Q62220766,"High-temperature-induced dauer-formation protein, putative",none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.46
high temperature,Q98918432,High Temperature – Small- Scale Sub-Surface Deformation assisted by Oxidation,none,0,0,2.6,0.0,1.0,0.0,30.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.18
high temperature,Q61543466,"High-temperature-induced dauer-formation protein, putative",none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.46
high temperature,Q26357279,High-temperature Combustion of Coal Seeded With Potassium Carbonate in the Mhd Generation of Electric Power,none,0,0,3.4,0.0,1.0,0.0,22.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.12
high temperature,Q28562973,HtrA serine peptidase 4,none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.46
high temperature,Q29525300,HtrA serine peptidase 2,none,0,0,4.3,0.0,1.0,0.0,26.4,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.19
high temperature,Q62319838,High temperature induced dauer formation protein,none,0,0,3.4,0.0,1.0,5.0,26.4,40.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.49
high temperature,Q62157659,"High-temperature-induced dauer-formation protein, putative",none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.46
high temperature,Q28560409,HtrA serine peptidase 1,none,0,0,3.4,0.0,1.0,0.0,26.4,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.92
high temperature,Q21981431,HtrA serine peptidase 4,none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.66
high temperature,Q62206912,"High-temperature-induced dauer-formation protein, putative",none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.46
high temperature,Q29831929,HtrA serine peptidase 1b,none,0,0,2.6,0.0,1.0,0.0,26.4,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.34
high temperature,Q62208023,"High-temperature-induced dauer-formation protein, putative",none,0,0,2.6,0.0,1.0,5.0,26.4,40.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.46
high temperature,Q62366911,TsM_000795400.1,none,0,0,5.1,0.0,1.0,5.0,26.4,40.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.54
high temperature,Q26376294,High Temperature Laser-induced Reactions Between Sulfur and Hydrocarbons,none,0,0,3.4,0.0,1.0,0.0,29.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.2
high temperature,Q1622414,réacteur à lit de boulets,none,0,0,2.6,2.89,0.0,4.0,0.0,37.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.22
mathematical morphology,Q530242,mathematical morphology,label,1,0,7.4,3.09,0.0,2.0,0.0,34.0,0.4,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,59.87
mathematical morphology,Q106087655,"Mathematical Morphology and Its Applications to Signal and Image Processing - 12th International Symposium, ISMM 2015, Reykjavik, Iceland, May 27-29, 2015",none,0,0,4.9,0.0,1.0,0.0,39.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.12
mathematical morphology,Q106245236,"Mathematical Morphology and Its Application to Signal and Image Processing, 9th International Symposium, ISMM 2009, Groningen, The Netherlands, August 24-27, 2009",none,0,0,6.2,0.0,1.0,0.0,39.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.61
mathematical morphology,Q106245234,"Mathematical Morphology and Its Applications to Image and Signal Processing - 10th International Symposium, ISMM 2011, Verbania-Intra, Italy, July 6-8, 2011",none,0,0,4.9,0.0,1.0,0.0,39.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.12
segmentation,Q2266173,speech segmentation,alias,0,1,4.9,2.71,0.0,10.0,0.0,42.6,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,56.62
segmentation,Q1423946,segmentation,label,1,0,6.2,2.89,1.0,2.0,40.6,46.4,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,58.23
segmentation,Q363057,market segmentation,alias,0,1,4.9,3.76,0.0,4.0,0.0,47.3,0.333,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,52.23
segmentation,Q21495952,"V-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian)",none,0,0,2.5,0.0,1.0,5.0,32.1,42.9,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.03
segmentation,Q1062340,segmentation fault,none,0,0,9.9,3.14,0.0,4.0,0.0,44.6,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.03
segmentation,Q47790744,Segmentation Vault,none,0,0,2.5,0.0,1.0,0.0,38.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.15
segmentation,Q62293518,segmentation protein even skipped,none,0,0,2.5,0.0,1.0,5.0,32.1,42.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.43
segmentation,Q7446280,Segmentation and Reassembly,none,0,0,3.7,0.69,1.0,0.0,24.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.83
segmentation,Q123372712,Segmentation: The Annelid Worms,none,0,0,3.7,0.0,1.0,0.0,28.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.53
segmentation,Q24387675,LOC102550651,none,0,0,3.7,0.0,1.0,2.0,22.3,30.4,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.91
segmentation,Q56933,image segmentation,none,0,0,7.4,3.22,1.0,1.0,44.6,28.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.57
segmentation,Q376172,segmentation,label,1,0,1.2,3.53,0.0,4.0,0.0,45.5,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,48.72
segmentation,Q796829,segmentation,label,1,0,1.2,3.22,0.0,4.0,0.0,42.8,0.286,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,44.58
segmentation,Q1127214,segmentation,label,1,0,8.6,3.3,0.0,7.0,0.0,43.6,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,74.48
segmentation,Q3477744,segmentation réseau,none,0,0,4.9,1.79,0.0,2.0,0.0,37.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.32
segmentation,Q25394236,segmentation  en mots,none,0,0,6.2,1.39,0.0,2.0,0.0,44.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.66
segmentation,Q245683,Segmentation en plans,none,0,0,3.7,1.95,1.0,0.0,27.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.99
segmentation,Q4692263,agrégation,none,0,0,1.2,0.69,1.0,0.0,28.0,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.91
directed acyclic graphs,Q1195339,directed acyclic graph,label,1,0,3.7,3.26,0.0,6.0,0.0,38.8,0.25,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,54.82
directed acyclic graphs,Q134939339,directed acyclic graph ledger,none,0,0,12.8,0.0,1.0,4.0,31.4,44.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,20.14
digital geometry,Q1789829,digital geometry,label,1,0,3.4,2.08,1.0,3.0,36.1,47.4,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,50.73
laplace-beltrami operator,Q1071846,Laplace–Beltrami operator,none,0,0,0.0,2.48,2.0,0.0,43.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.27
optimal transport,Q1280998,optimal transport,label,1,0,0.0,1.39,1.0,0.0,32.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.25
geometry,Q8087,geometry,label,1,0,5.1,5.36,1.0,2.0,36.1,46.9,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,67.43
geometry,Q207961,shape,alias,0,1,1.7,4.26,1.0,5.0,32.1,39.8,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,47.2
geometry,Q5535522,geometry and topology,none,0,0,8.5,1.1,1.0,0.0,36.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.88
geometry,Q1412851,Geant4,none,0,0,1.7,2.4,4.0,0.0,44.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.38
geometry,Q27980524,Geometry,label,1,0,0.0,1.39,1.0,0.0,41.7,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.46
geometry,Q825762,GeForce,none,0,0,1.7,3.61,1.0,3.0,25.0,48.3,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.54
geometry,Q19911814,Geometry,label,1,0,0.0,0.0,1.0,0.0,34.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,26.75
geometry,Q1647152,shape of the universe,none,0,0,5.1,3.3,4.0,4.0,49.4,44.6,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.95
geometry,Q16190030,Geometry Dash,none,0,0,3.4,3.56,2.0,0.0,46.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.11
geometry,Q18705896,Geometry Wars 3: Dimensions,none,0,0,0.0,1.61,1.0,0.0,36.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.98
geometry,Q84697032,Geometry,label,1,0,0.0,0.69,1.0,0.0,38.4,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.62
geometry,Q111226038,Geometry,label,1,0,3.4,0.0,0.0,3.0,0.0,40.6,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,38.15
geometry,Q2293593,Geometry Wars: Retro Evolved,none,0,0,0.0,1.79,1.0,0.0,36.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.27
geometry,Q2393733,history of geometry,none,0,0,8.5,3.18,1.0,0.0,39.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.96
geometry,Q1503283,GEOS,none,0,0,1.7,1.1,1.0,0.0,37.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.76
geometry,Q46409818,Geometry Dash SubZero,none,0,0,3.4,1.1,1.0,0.0,36.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.79
geometry,Q3101005,Geo-Mod,none,0,0,0.0,1.39,2.0,0.0,43.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.73
geometry,Q69506271,Geometry Wars,none,0,0,0.0,1.79,1.0,0.0,34.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.04
geometry,Q3038439,GNU Dr. Geo,none,0,0,0.0,2.3,5.0,0.0,43.5,0.0,0.118,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.94
geometry,Q16839842,Geometry Wars: Galaxies,none,0,0,0.0,1.39,1.0,0.0,36.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.86
geometry,Q8843588,geometry set,none,0,0,1.7,0.69,0.0,6.0,0.0,40.4,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.3
geometry,Q43677964,Geometry Dash World,none,0,0,1.7,0.69,1.0,0.0,36.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.55
geometry,Q5535519,Geometry Wars: Retro Evolved 2,none,0,0,0.0,1.39,1.0,0.0,36.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.86
geometry,Q77663563,geometry terminology,none,0,0,1.7,0.0,0.0,2.0,0.0,45.6,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.6
geometry,Q21008562,Geometry of Fear,none,0,0,1.7,1.1,2.0,0.0,46.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.65
geometry,Q5535528,Geometry Prize,none,0,0,1.7,1.61,1.0,0.0,43.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.07
geometry,Q5535520,Geometry Wars: Touch,none,0,0,0.0,1.39,1.0,0.0,36.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.86
geometry,Q5535521,Geometry Wars: Waves,none,0,0,0.0,1.1,1.0,0.0,36.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.72
geometry,Q96797223,Geometry A,none,0,0,1.7,2.08,1.0,0.0,41.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.29
geometry,Q28975884,Geometry Data File,none,0,0,0.0,0.0,1.0,0.0,37.2,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.67
geometry,Q111226248,GeometryCollection,none,0,0,3.4,0.0,1.0,2.0,35.6,36.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.21
geometry,Q6784077,mass point geometry,none,0,0,6.8,1.39,1.0,2.0,36.1,46.7,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.76
geometry,Q22908588,GEANT-3,none,0,0,1.7,0.69,2.0,0.0,44.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.63
geometry,Q114299337,Geometry and Measurement,none,0,0,3.4,0.0,1.0,3.0,22.3,31.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.14
geometry,Q1466519,geometry of numbers,none,0,0,3.4,2.77,0.0,2.0,0.0,48.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.05
geometry,Q52610115,"Geometry Balkan Press, Bucharest",none,0,0,0.0,0.0,1.0,0.0,33.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.14
geometry,Q21674221,Geometry and Arithmetic,none,0,0,1.7,0.0,1.0,0.0,34.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.18
geometry,Q65064934,Geometry,label,1,0,0.0,2.71,1.0,0.0,22.0,0.0,0.4,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.92
geometry,Q5535529,geometry processing,none,0,0,10.2,1.95,0.0,2.0,0.0,43.3,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.72
geometry,Q835065,moment quadratique,none,0,0,0.0,3.33,0.0,4.0,0.0,44.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
geometry,Q1133467,centre de l'Europe,none,0,0,0.0,3.22,1.0,0.0,34.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.75
geometry,Q22635388,Geometry Lake,none,0,0,0.0,1.1,1.0,0.0,30.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.65
geometry,Q2579316,Orthonama obstipata,none,0,0,0.0,2.4,1.0,0.0,40.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.4
geometry,Q51783029,"Geometry, Arithmetic, Algorithms, Codes And Encryption",none,0,0,1.7,0.0,1.0,0.0,43.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.27
discrete calculus,Q20968946,difference calculus,alias,0,1,5.1,1.61,1.0,0.0,36.1,0.0,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,42.94
discrete curvature,Q111026320,Discrete Curvature Theories and Applications,none,0,0,6.8,0.0,1.0,0.0,35.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.29
fast fourier transform,Q623950,fast Fourier transform,label,1,0,3.7,3.43,0.0,6.0,0.0,45.6,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,55.99
spherical harmonics,Q877100,spherical harmonic,label,1,1,5.4,3.4,1.0,0.0,33.9,0.0,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,15.0,68.75
spherical harmonics,Q7576707,Spherical harmonic lighting,none,0,0,0.9,0.69,1.0,0.0,4.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.26
random field,Q5361768,random field,label,1,0,3.4,2.48,0.0,3.0,0.0,42.1,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,49.63
random field,Q56550308,Random Fields and Geometry,none,0,0,3.4,0.0,1.0,0.0,13.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.07
adaptive algorithm,Q1988072,adaptive algorithm,label,1,0,5.2,1.95,0.0,5.0,0.0,48.8,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,55.78
uncertainty quantification,Q7882499,uncertainty quantification,label,1,0,4.3,0.69,0.0,3.0,0.0,46.2,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,43.13
uncertainty quantification,Q111026956,Uncertainty Quantification and Assimilation for Efficient Coastal Ocean Forecasting,none,0,0,3.4,0.0,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.17
uncertainty quantification,Q99980222,Uncertainty Quantification And Design Tools For Robust Organic Rankine Cycles,none,0,0,3.4,0.0,2.0,0.0,34.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.08
random vector,Q3179949,multivariate random variable,alias,0,1,7.4,2.56,0.0,6.0,0.0,44.5,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,59.49
high dimension,Q15039945,high-dimensional space,none,0,0,9.3,1.39,1.0,3.0,24.9,47.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,17.04
high dimension,Q135022631,High Dimension,label,1,0,3.7,0.0,1.0,0.0,32.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,37.84
high dimension,Q112954267,High Dimensional Analysis of Myeloid Cells in Colorectal Cancer,none,0,0,3.7,0.0,1.0,0.0,30.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.55
high dimension,Q105627812,high-dimensional information,none,0,0,0.0,0.0,0.0,3.0,0.0,48.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.19
multimodal probability distribution,Q85900768,multimodal distribution,alias,0,1,3.7,1.79,0.0,5.0,0.0,49.2,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,44.35
multiprocessor,Q1126251,food processor,alias,0,1,1.5,3.56,0.0,10.0,0.0,49.0,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,46.76
multiprocessor,Q3822650,multiprocessor system,none,0,0,0.8,2.77,0.0,4.0,0.0,48.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.74
multiprocessor,Q4043398,MC#,none,0,0,1.5,1.39,1.0,0.0,29.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.59
multiprocessor,Q178677,symmetric multiprocessing,none,0,0,8.3,3.14,0.0,2.0,0.0,42.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.03
real-time,Q856198,real-time polymerase chain reaction,none,0,0,3.0,3.37,2.0,7.0,28.8,44.8,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.34
real-time,Q208189,real-time strategy,none,0,0,1.5,3.91,1.0,3.0,17.3,34.7,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
real-time,Q2313710,real-time tactics,none,0,0,0.8,2.94,1.0,6.0,17.3,40.7,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.13
real-time,Q347066,real-time,label,1,0,3.0,2.64,1.0,5.0,19.6,48.3,0.4,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,52.08
real-time,Q2706514,Real Time,none,0,0,0.8,2.48,1.0,0.0,30.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.25
real-time,Q213666,real-time operating system,none,0,0,3.0,3.64,0.0,2.0,0.0,37.1,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.78
real-time,Q13479657,real-time MRI,none,0,0,0.8,1.79,0.0,3.0,0.0,38.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.4
real-time,Q7094097,online machine learning,none,0,0,7.5,2.83,0.0,4.0,0.0,49.7,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.09
real-time,Q3988,real-time computing,none,0,0,4.5,3.47,1.0,4.0,14.2,45.4,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.85
real-time,Q74023731,real-time pacing,none,0,0,1.5,0.0,1.0,0.0,37.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.98
real-time,Q2030903,Real Time with Bill Maher,none,0,0,3.0,2.83,1.0,0.0,26.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.09
real-time,Q29729059,retm,alias,0,1,1.5,0.0,1.0,0.0,15.5,0.0,0.333,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,24.05
real-time,Q64157236,RT-QuIC,none,0,0,0.0,0.0,1.0,0.0,26.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.06
real-time,Q16956307,Theranos,none,0,0,0.0,3.22,2.0,0.0,43.8,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.15
real-time,Q111938116,Real Time,none,0,0,1.5,1.1,2.0,0.0,35.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.3
real-time,Q29818672,Real-time Dmel_CG9528,none,0,0,0.8,0.0,1.0,0.0,25.9,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.51
real-time,Q753532,real time,none,0,0,0.8,1.79,1.0,3.0,21.1,43.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.96
real-time,Q862594,real-time clock,none,0,0,4.5,3.26,0.0,8.0,0.0,48.3,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.43
real-time,Q321213,Real-time Transport Protocol,none,0,0,1.5,3.66,2.0,0.0,25.2,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.15
real-time,Q7301079,Real Time,none,0,0,0.8,0.69,1.0,0.0,25.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.31
real-time,Q1680302,real-time gross settlement,none,0,0,0.0,3.0,0.0,3.0,0.0,37.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
real-time,Q682598,Real Time Streaming Protocol,none,0,0,0.8,3.37,1.0,0.0,17.2,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.56
real-time,Q65067684,Zimbabwean dollar,none,0,0,3.0,2.4,2.0,0.0,28.6,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.2
real-time,Q7915726,variable pricing,none,0,0,3.0,1.1,0.0,2.0,0.0,33.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.62
real-time,Q1661052,Indeo,none,0,0,3.0,2.71,3.0,0.0,37.7,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.94
real-time,Q6595534,"Real Time with Bill Maher, season 5",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q27973,ridesharing company,none,0,0,1.5,2.94,0.0,12.0,0.0,49.4,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.54
real-time,Q1141977,Real-time locating system,none,0,0,0.0,2.4,0.0,3.0,0.0,39.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.31
real-time,Q47483483,RFC 2326: Real Time Streaming Protocol (RTSP),none,0,0,1.5,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.32
real-time,Q17102633,"Real Time with Bill Maher, season 8",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q28455051,"Real Time with Bill Maher, season 15",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q25222160,"Real Time with Bill Maher, season 14",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q17102628,"Real Time with Bill Maher, season 7",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q17102611,"Real Time with Bill Maher, season 3",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q21067651,"Real Time with Bill Maher, season 13",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q17102606,"Real Time with Bill Maher, season 2",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q48845636,"Real Time with Bill Maher, season 16",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q17102649,"Real Time with Bill Maher, season 12",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q60772470,"Real Time with Bill Maher, season 17",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q749940,Real-time Transport Control Protocol,none,0,0,2.3,3.09,1.0,0.0,17.2,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.22
real-time,Q17102621,"Real Time with Bill Maher, season 6",none,0,0,2.3,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.06
real-time,Q3421656,Realtime Worlds,none,0,0,0.8,1.79,1.0,0.0,26.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.36
real-time,Q29867401,Computer Quarterback,none,0,0,0.0,1.1,1.0,0.0,21.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.57
real-time,Q787012,Real Time Messaging Protocol,none,0,0,2.3,2.71,1.0,0.0,17.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.03
real-time,Q2134714,Real Time Bidding,none,0,0,0.8,2.64,1.0,0.0,17.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.2
real-time,Q135005,hameçonnage,none,0,0,0.8,4.42,1.0,8.0,16.7,46.7,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.0
real-time,Q1600588,RTEMS,none,0,0,0.8,2.56,2.0,0.0,31.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.6
EDF,Q18027927,INHBA,alias,0,1,2.3,1.79,1.0,2.0,15.5,22.9,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,35.44
EDF,Q327827,Estonian Defence Forces,alias,0,1,1.5,3.64,1.0,0.0,18.4,0.0,0.333,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,38.66
EDF,Q14877650,IL5,alias,0,1,2.3,3.0,1.0,2.0,15.5,22.9,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,40.26
EDF,Q14679983,Elmendorf Air Force Base,alias,0,1,1.5,2.48,1.0,0.0,23.8,0.0,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,33.77
EDF,Q1148639,Joint Base Elmendorf-Richardson,alias,0,1,1.5,2.89,1.0,0.0,25.5,0.0,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,36.33
EDF,Q21107468,Inhibin subunit beta A,alias,0,1,2.3,0.0,1.0,0.0,25.9,0.0,0.154,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,25.06
EDF,Q15331450,RHOA,none,0,0,1.5,1.79,1.0,2.0,15.5,22.9,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.79
EDF,Q53574518,Éclaireurs de France,none,0,0,0.0,0.0,1.0,0.0,31.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.31
EDF,Q352571,European Data Format,alias,0,1,0.8,1.61,1.0,0.0,24.1,0.0,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,29.73
EDF,Q239107,Edfu,none,0,0,2.3,4.09,2.0,0.0,19.8,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.75
EDF,Q11252173,European Disability Forum (EDF),alias,0,1,0.8,2.08,2.0,0.0,42.3,0.0,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,32.74
EDF,Q666365,earliest deadline first scheduling,alias,0,1,3.8,2.71,1.0,2.0,63.4,29.5,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,45.49
EDF,Q158211,Hahn Airport,none,0,0,0.8,3.71,2.0,0.0,28.5,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.24
EDF,Q613037,Temple of Edfu,none,0,0,3.0,3.81,4.0,0.0,43.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.65
EDF,Q3045865,EDF Energy,none,0,0,2.3,2.08,1.0,0.0,36.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.91
EDF,Q18033241,EDF1,none,0,0,1.5,2.2,1.0,2.0,15.5,22.9,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.24
EDF,Q48754715,Earth Defense Force 5,none,0,0,1.5,1.39,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.01
EDF,Q110937831,EDF Renewables North America,none,0,0,1.5,0.0,1.0,0.0,36.5,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.72
EDF,Q47477401,Edfelt,none,0,0,0.0,0.69,1.0,0.0,27.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.42
EDF,Q18258945,Edf1,none,0,0,1.5,0.0,1.0,2.0,15.5,22.9,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.14
EDF,Q29758922,edf1,none,0,0,1.5,0.0,1.0,0.0,15.5,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.96
EDF,Q24372709,Edf1,none,0,0,1.5,0.0,1.0,2.0,15.5,22.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.64
EDF,Q106848362,Edfeldt,none,0,0,0.0,0.0,1.0,0.0,27.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.07
EDF,Q21132811,Endothelial differentiation related factor 1,none,0,0,1.5,0.0,1.0,0.0,25.9,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.72
EDF,Q33073417,Edfors,none,0,0,0.0,0.69,1.0,0.0,27.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.42
EDF,Q3047408,Edfrid A. Bingham,none,0,0,0.8,0.69,1.0,0.0,30.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.36
EDF,Q1278153,Reichelsheim airfield,none,0,0,0.8,1.79,1.0,0.0,22.0,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.02
EDF,Q75382376,Eadflæd,none,0,0,0.8,0.0,1.0,0.0,30.9,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.51
EDF,Q104538074,Apollinopolis Magna,none,0,0,0.8,1.1,1.0,0.0,16.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.42
EDF,Q321656,Mainz-Finthen airfield,none,0,0,0.8,2.2,1.0,0.0,22.0,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.88
EDF,Q108750065,Earth Defense Force 6,none,0,0,0.0,0.69,1.0,0.0,21.6,0.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.22
EDF,Q28539527,"Edfu, Upper Egypt",none,0,0,0.8,0.0,1.0,0.0,21.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.91
EDF,Q3045860,EDF/GDF,none,0,0,0.8,0.69,2.0,0.0,30.4,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.7
EDF,Q105733827,EDF Sport Énergie,none,0,0,0.8,0.0,1.0,0.0,21.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.92
EDF,Q5337070,Edford Township,none,0,0,0.8,2.2,1.0,0.0,21.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.02
EDF,Q1603917,Edfu South Pyramid,none,0,0,0.0,1.95,2.0,0.0,31.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.88
EDF,Q895664,Allendorf/Eder airfield,none,0,0,0.8,1.95,1.0,0.0,22.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.9
EDF,Q1433732,Michelstadt/Odw. airfield,none,0,0,0.8,1.61,1.0,0.0,15.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.66
EDF,Q1294042,Worms airfield,none,0,0,0.8,1.61,1.0,0.0,22.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.23
EDF,Q1433465,Anspach/Taunus airfield,none,0,0,0.8,1.61,1.0,0.0,15.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.66
EDF,Q12694229,Ober-Mörlen airfield,none,0,0,0.8,1.61,1.0,0.0,15.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.66
EDF,Q160659,London Eye,none,0,0,0.8,4.37,2.0,0.0,31.8,0.0,0.143,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.43
EDF,Q315060,aéroport de Mannheim,none,0,0,0.8,2.4,1.0,0.0,22.0,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.62
EDF,Q1359305,Amplificateur optique,none,0,0,1.5,3.26,0.0,2.0,0.0,33.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.4
EDF,Q1364853,Coupe d'Angleterre de rugby à XV,none,0,0,0.8,2.64,1.0,0.0,26.7,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.95
EDF,Q11992617,EDF Norte Fluminense,none,0,0,0.8,1.1,2.0,0.0,27.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.83
EDF,Q1615045,Robertsfors,none,0,0,0.0,3.22,1.0,0.0,23.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.64
EDF,Q85304066,European Down and Feather Association,none,0,0,0.8,0.0,1.0,0.0,30.8,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.51
EDF,Q120188132,Edf de Carcassonne,none,0,0,0.0,0.0,1.0,0.0,26.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.07
EDF,Q120195861,Edf de Carpentras,none,0,0,0.0,0.0,1.0,0.0,26.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.07
EDF,Q1345899,Environmental Defense Fund,alias,0,1,1.5,1.95,3.0,0.0,44.4,0.0,1.0,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,40.89
EDF,Q327578,Johannes Edfelt,none,0,0,0.0,2.3,1.0,0.0,30.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.26
EDF,Q523542,Catti Edfeldt,none,0,0,0.8,2.08,1.0,0.0,30.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
performance evaluation,Q1430184,performance appraisal,alias,0,1,6.8,3.22,1.0,5.0,25.0,45.0,0.222,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,57.68
performance evaluation,Q26363546,Performance evaluation of automated extraction system. Volume 5. Geotechnical investigations of the roof conditions in the area mined by the AES machine,none,0,0,4.5,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.47
performance evaluation,Q106246368,"Performance Evaluation and Benchmarking, First TPC Technology Conference, TPCTC 2009, Lyon, France, August 24-28, 2009",none,0,0,2.3,0.0,1.0,0.0,33.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.84
performance evaluation,Q106339358,"Performance Evaluation and Benchmarking for the Era of Artificial Intelligence - 10th TPC Technology Conference, TPCTC 2018, Rio de Janeiro, Brazil, August 27-31, 2018",none,0,0,3.8,0.0,1.0,0.0,33.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.64
performance evaluation,Q26359010,Performance evaluation of automated extraction system. Volume 6. An assessment of AES operation on mine strata,none,0,0,3.8,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.56
performance evaluation,Q47169100,RFC 6687: Performance Evaluation of the Routing Protocol for Low-Power and Lossy Networks (RPL),none,0,0,3.8,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.03
performance evaluation,Q106339357,"Performance Evaluation and Benchmarking for the Era of Cloud(s) - 11th TPC Technology Conference, TPCTC 2019, Los Angeles, CA, USA, August 26, 2019",none,0,0,3.8,0.0,1.0,0.0,33.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.64
performance evaluation,Q113916089,Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T,none,0,0,4.5,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.47
performance evaluation,Q26358621,Performance Evaluation of Automated Extraction System. Volume 1-4,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q61918287,Performance Evaluation and Research for Older Adults Requiring Major Surgery,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q7118987,PEPA,none,0,0,0.8,0.69,2.0,0.0,33.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.18
performance evaluation,Q66357298,Performance Evaluation of Vector 60 Pound Thrust Engine (NAID 101940612),none,0,0,3.8,0.0,1.0,0.0,32.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.64
performance evaluation,Q63319619,Performance Evaluation of the NaviAid™ G-Eye System,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q64604558,Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay,none,0,0,3.0,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.66
performance evaluation,Q63808500,"Performance Evaluation of the Nanomix eLab® CRP, PCT, and LAC Assays With the Nanomix eLab System",none,0,0,3.8,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.56
performance evaluation,Q64394286,Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q64637389,Performance Evaluation on the Upper Limb Closed Kinetic Chain Test After Scapular Elastic Taping on Jiu Jitsu Practitioners,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q64210135,Performance Evaluation and Selection Board Records (NAID 28794071),none,0,0,3.0,0.0,1.0,0.0,25.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.67
performance evaluation,Q66152841,Performance Evaluation Files Relating to the Space Station Freedom (NAID 7543174),none,0,0,3.8,0.0,1.0,0.0,25.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.57
performance evaluation,Q66357299,Performance Evaluation of Vector 60 Pound Thrust Engine (NAID 101940613),none,0,0,3.8,0.0,1.0,0.0,32.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.64
performance evaluation,Q66409575,Performance Evaluation of Clinical Ultrasound in Management of Acute Pulmonary Edema in Elderly Patient,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q63319688,Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers,none,0,0,3.8,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.56
performance evaluation,Q63613515,Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat,none,0,0,3.0,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.66
performance evaluation,Q64267996,"Performance Evaluation Files, Budget Estimate Files, and Operating Budget Files (NAID 22345820)",none,0,0,3.0,0.0,1.0,0.0,25.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.67
performance evaluation,Q61957252,Performance Evaluation of Blood Glucose Monitoring Systems,none,0,0,1.5,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.86
performance evaluation,Q66401983,Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding,none,0,0,3.8,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.56
performance evaluation,Q61938014,Performance Evaluation Study for Clearblue Pregnancy Test,none,0,0,2.3,0.0,1.0,0.0,25.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
performance evaluation,Q26357891,Performance evaluation of solid cementitious seals,none,0,0,2.3,0.0,1.0,0.0,19.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.71
performance evaluation,Q47476844,RFC 2884: Performance Evaluation of Explicit Congestion Notification (ECN) in IP Networks,none,0,0,3.0,0.0,1.0,0.0,21.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.13
semantic interoperability,Q5258530,semantic interoperability,label,1,0,5.6,2.08,0.0,2.0,0.0,43.3,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,51.52
semantic interoperability,Q110392268,Semantic Interoperability Community,none,0,0,4.8,0.0,1.0,0.0,21.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.73
semantic interoperability,Q7449030,Semantic Interoperability Community of Practice,none,0,0,2.4,0.69,1.0,0.0,24.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.25
health information systems,Q113168820,health information systems research,none,0,0,3.2,0.0,1.0,0.0,20.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.81
information model,Q1662581,information model,label,1,0,6.3,2.56,2.0,2.0,38.1,38.9,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,59.25
information model,Q47467824,RFC 5102: Information Model for IP Flow Information Export,none,0,0,1.6,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
information model,Q47468944,RFC 7012: Information Model for IP Flow Information Export (IPFIX),none,0,0,1.6,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
information model,Q106333424,"Information Modelling and Knowledge Bases XXXI - 29th International Conference on Information Modelling and Knowledge Bases, EJC 2019, Lappeenranta, Finland, June 3-7 2019",none,0,0,3.2,0.0,1.0,0.0,33.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.95
information model,Q47164779,RFC 5477: Information Model for Packet Sampling Exports,none,0,0,1.6,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
information model,Q106243576,"Information Modelling and Knowledge Bases XXVII, 25th International Conference on Information Modelling and Knowledge Bases (EJC 2015), Maribor, Slovenia, June 8-12, 2015",none,0,0,3.2,0.0,1.0,0.0,33.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.95
information model,Q106333427,"Information Modelling and Knowledge Bases XXVIII, 26th International Conference on Information Modelling and Knowledge Bases (EJC 2016), Tampere, Finland, June 6-10, 2016",none,0,0,3.2,0.0,1.0,0.0,33.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.95
information model,Q47484693,RFC 8193: Information Model for Large-Scale Measurement Platforms (LMAPs),none,0,0,1.6,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
information model,Q56578952,RFC 8454: Information Model for Abstraction and Control of TE Networks (ACTN),none,0,0,3.2,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
information model,Q47483442,RFC 3670: Information Model for Describing Network Device QoS Datapath Mechanisms,none,0,0,1.6,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
information model,Q47462198,RFC 5388: Information Model and XML Data Model for Traceroute Measurements,none,0,0,3.2,0.0,1.0,0.0,22.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
semantic web,Q54837,Semantic Web,label,1,0,6.3,3.83,5.0,9.0,48.2,51.9,0.286,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,81.11
semantic web,Q60485945,Semantic Web,label,1,0,1.6,0.0,1.0,0.0,28.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.38
semantic web,Q58821780,Proceedings of the 5th International Workshop on Semantic Web Applications and Tools for Life Sciences,none,0,0,6.3,0.0,1.0,0.0,32.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.24
semantic web,Q27726215,The Semantic Web - ISWC,none,0,0,3.2,0.0,1.0,0.0,14.4,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.75
semantic web,Q29129469,Semantic Web in Libraries Conference,none,0,0,4.0,0.0,2.0,4.0,34.8,42.3,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.95
semantic web,Q56846035,Semantic Web Applications and Tools for Healthcare and Life Sciences,none,0,0,4.0,0.0,1.0,0.0,28.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.85
semantic web,Q1482252,Semantic Web Service,none,0,0,1.6,1.79,0.0,2.0,0.0,41.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.33
semantic web,Q51758120,SWIB18,none,0,0,2.4,0.69,2.0,0.0,39.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.7
semantic web,Q58821312,Proceedings of the Workshop on Semantic Web Applications and Tools for Life Sciences,none,0,0,5.6,0.0,1.0,0.0,32.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.79
semantic web,Q56539593,Semantic Web Framework,none,0,0,3.2,0.0,2.0,2.0,38.1,40.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.31
semantic web,Q59264323,SWIB19,none,0,0,2.4,0.0,2.0,0.0,39.7,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
semantic web,Q44801561,SWIB17,none,0,0,2.4,0.0,2.0,0.0,39.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
semantic web,Q45247941,SWIB15,none,0,0,2.4,0.0,2.0,0.0,34.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.3
semantic web,Q44834930,SWIB16,none,0,0,2.4,0.0,2.0,0.0,39.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
semantic web,Q3478367,Semantic Web Rule Language,none,0,0,5.6,1.1,4.0,0.0,46.1,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.08
semantic web,Q106067050,"Semantic Web - Joint International Semantic Technology Conference, JIST 2011, Hangzhou, China, December 4-7, 2011",none,0,0,2.4,0.0,1.0,0.0,33.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
semantic web,Q106067117,"Semantic Web and Web Science - 8th Chinese Conference, CSWS 2014, Wuhan, China, August 8-12, 2014",none,0,0,2.4,0.0,1.0,0.0,33.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
semantic web,Q113582035,Semantic Web Challenge on Mining the Web of HTML-embedded Product Data,none,0,0,4.8,0.0,1.0,0.0,6.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.58
semantic web,Q113674234,Semantic Web in Provenance Management SWPM-2009,none,0,0,2.4,0.0,1.0,0.0,6.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.72
semantic web,Q60675028,Semantic Web for Earth and Environmental Terminology,none,0,0,4.0,0.0,1.0,0.0,28.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.85
semantic web,Q97119874,Semantic Web and Linked Data Research Guide (UCLA Library),none,0,0,4.8,0.0,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.74
semantic web,Q113674245,Semantic Web and New Technologies,none,0,0,3.2,0.0,1.0,0.0,6.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.67
semantic web,Q115250771,Semantic Web Challenge on Knowledge Base Construction from Pre-trained Language Models 2022,none,0,0,3.2,0.0,2.0,0.0,19.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.6
semantic web,Q105696294,Semantic Web Applications and Perspectives,none,0,0,2.4,0.0,1.0,0.0,28.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.94
semantic web,Q113582110,Semantic Web Challenge on Tabular Data to Knowledge Graph Matching (SemTab 2020),none,0,0,4.0,0.0,2.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.55
semantic web,Q113673292,Semantic Web Challenge 2007,none,0,0,1.6,0.0,1.0,0.0,6.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.77
semantic web,Q113649505,Semantic Web for the Law and Second Doctoral Consortium Workshops,none,0,0,4.0,0.0,1.0,0.0,6.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.62
semantic web,Q113673291,"Semantic Web and Web 2.0 in Architectural, Product and Engineering Design",none,0,0,4.0,0.0,1.0,0.0,6.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.62
semantic web,Q109744747,Semantic Web und LOD in der digitalen Archäologie Ein Blick in die Praxis,none,0,0,2.4,0.0,1.0,0.0,20.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.86
semantic web,Q116156382,Semantic Web Challenge on Tabular Data to Knowledge Graph Matching,none,0,0,4.0,0.0,2.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.55
semantic web,Q21830201,Semantic Web task force,none,0,0,2.4,0.69,1.0,0.0,25.4,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.46
semantic web,Q125207931,semantic web challenge chair,none,0,0,3.2,0.0,0.0,2.0,0.0,23.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.2
semantic web,Q120636485,Semantic Web Construction: An Inquiry of Authors’ Views on Collaborative Metadata Generation,none,0,0,7.1,0.0,1.0,0.0,20.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.58
semantic web,Q120910069,Semantic Web of Things,none,0,0,2.4,0.0,3.0,0.0,41.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.67
semantic web,Q113546206,Semantic Web Workshop 2002,none,0,0,2.4,0.0,1.0,0.0,32.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.98
image processing,Q327008,image processing,label,1,0,9.3,3.61,0.0,6.0,0.0,50.7,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,75.09
image processing,Q1070689,digital image processing,none,0,0,3.4,3.43,0.0,4.0,0.0,51.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.1
image processing,Q15623421,image processing software,none,0,0,2.5,0.0,1.0,4.0,14.0,46.4,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.76
image processing,Q861004,image processor,none,0,0,2.5,2.3,0.0,2.0,0.0,40.2,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.58
image processing,Q30263217,Image Processing Systems Institute,none,0,0,2.5,0.0,1.0,0.0,25.2,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.3
image processing,Q114944645,image processing algorithm,none,0,0,1.7,0.0,0.0,3.0,0.0,38.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.15
image processing,Q28206383,Image Processing Lab,none,0,0,1.7,0.0,1.0,0.0,25.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.59
image processing,Q105698645,Image Processing: Algorithms and Systems,none,0,0,2.5,0.0,1.0,0.0,29.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.15
image processing,Q105699627,"Image Processing, Image Quality, Image Capture Systems Conference",none,0,0,1.7,0.0,1.0,0.0,29.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.13
image processing,Q106335539,"Image Processing: Algorithms and Systems XVII, Burlingame, CA, USA, 13-17 January 2019",none,0,0,2.5,0.0,1.0,0.0,35.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.21
image processing,Q106335541,"Image Processing: Algorithms and Systems VI, San Jose, California, USA, January 28-29, 2008",none,0,0,2.5,0.0,1.0,0.0,35.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.21
image processing,Q106335542,"Image Processing: Algorithms and Systems II, Santa Clara, California, USA, January 20, 2003",none,0,0,2.5,0.0,1.0,0.0,35.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.21
image processing,Q52637379,Image Processing On Line,none,0,0,3.4,0.0,1.0,0.0,20.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.07
image processing,Q106335540,"Image Processing: Algorithms and Systems VII, San Jose, California, USA, January 19-22, 2009",none,0,0,2.5,0.0,1.0,0.0,35.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.21
image processing,Q13360783,Modèle:Palette Logiciels de traitement d'image,none,0,0,1.7,2.2,1.0,0.0,32.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.25
regularity,Q4184950,regularity,label,1,0,4.2,1.61,0.0,2.0,0.0,34.6,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,46.84
regularity,Q104058296,constraint qualification,none,0,0,0.8,0.0,0.0,2.0,0.0,32.6,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.48
regularity,Q442701,Regularity rally,none,0,0,1.7,2.08,0.0,4.0,0.0,47.7,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.86
regularity,Q63834080,REGULarity of Physical ActivitieS (REGUL'APS),none,0,0,1.7,0.0,1.0,0.0,26.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.09
regularity,Q64792820,Regularity of Lymphatic Drainage and Surgical Treatment of Breast Cancer,none,0,0,2.5,0.0,1.0,0.0,26.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.11
van gogh,Q224124,Van Gogh Museum,none,0,0,4.2,4.11,3.0,0.0,44.1,0.0,0.182,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.53
van gogh,Q42865365,van Gogh,label,1,0,1.7,1.1,2.0,0.0,35.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,38.25
van gogh,Q1272723,Van Gogh,label,1,0,1.7,2.48,1.0,0.0,21.5,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,41.5
van gogh,Q2509824,Van Gogh,label,1,0,2.5,2.56,1.0,0.0,22.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,44.37
van gogh,Q29829095,T-box transcription factor 1,alias,0,1,2.5,0.0,1.0,0.0,26.9,0.0,0.25,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,26.71
van gogh,Q154160,4457 van Gogh,alias,0,1,1.7,3.26,1.0,0.0,25.0,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,40.5
van gogh,Q21981325,VANGL planar cell polarity 2,none,0,0,1.7,0.0,1.0,0.0,26.9,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.77
van gogh,Q29723017,Vang,alias,0,1,3.4,0.0,1.0,0.0,17.3,0.0,0.154,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,28.31
van gogh,Q29826330,VANGL planar cell polarity protein 2,none,0,0,1.7,0.0,1.0,0.0,26.9,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.7
van gogh,Q28860334,Van Gogh,label,1,0,2.5,0.0,1.0,0.0,24.6,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.17
van gogh,Q28854520,Van Gogh,label,1,0,2.5,0.0,1.0,0.0,24.6,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.17
van gogh,Q28910311,Van Gogh,label,1,0,2.5,0.0,1.0,0.0,23.1,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.14
van gogh,Q61518785,van gogh,label,1,0,2.5,0.0,1.0,0.0,26.9,0.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,32.89
van gogh,Q15298485,van Gogh,label,1,0,1.7,2.4,1.0,0.0,28.8,0.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,39.98
van gogh,Q1118295,Van Gogh's Chair,none,0,0,4.2,2.89,1.0,0.0,22.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.76
van gogh,Q3630735,Self-portrait,none,0,0,5.1,3.0,1.0,0.0,22.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.83
van gogh,Q21136574,VANGL planar cell polarity protein 2,none,0,0,1.7,0.0,1.0,0.0,26.9,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.77
van gogh,Q15883459,Van Gogh Village Museum,none,0,0,4.2,1.1,1.0,0.0,32.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.76
van gogh,Q58317571,Van Gogh and Britain,none,0,0,3.4,1.1,1.0,0.0,26.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.68
van gogh,Q10896041,Van Goghhuis,none,0,0,3.4,1.39,1.0,0.0,32.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.38
van gogh,Q105322100,Van Gogh and Gauguin : the studio of the south,none,0,0,4.2,0.0,1.0,0.0,28.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.17
van gogh,Q21982915,VANGL planar cell polarity 1,none,0,0,1.7,0.0,1.0,0.0,26.9,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.7
van gogh,Q2517726,"Van Gogh church, Nuenen",none,0,0,3.4,1.1,1.0,0.0,16.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.58
van gogh,Q15883237,Van Gogh House,none,0,0,4.2,1.79,2.0,0.0,38.2,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.46
van gogh,Q28858175,Van Gogh and Nature,none,0,0,3.4,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
van gogh,Q110280042,Van Gogh Worldwide,none,0,0,4.2,0.0,2.0,0.0,14.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.83
van gogh,Q28841332,Van Gogh: Face to Face,none,0,0,3.4,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
van gogh,Q99397479,Van-Gogh-Straße,none,0,0,0.8,0.69,1.0,0.0,23.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.4
van gogh,Q100147586,Van Gogh Project,none,0,0,5.9,0.69,1.0,0.0,24.6,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.01
van gogh,Q28868160,Van Gogh in the Borinage: birth of an artist,none,0,0,5.9,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.16
van gogh,Q19620603,van Goghstraat,none,0,0,3.4,0.0,1.0,0.0,23.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
van gogh,Q106857584,Van-Gogh-Weg,none,0,0,2.5,0.0,1.0,0.0,23.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.09
van gogh,Q28863878,Van Gogh as Critic and Self-Critic,none,0,0,3.4,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
van gogh,Q28910510,Van Gogh in Paris,none,0,0,3.4,0.0,1.0,0.0,23.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.1
van gogh,Q21100614,VANGL planar cell polarity protein 1,none,0,0,1.7,0.0,1.0,0.0,26.9,0.0,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.7
van gogh,Q28834734,Van Gogh: Face to Face. The Portraits,none,0,0,3.4,0.0,1.0,0.0,28.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.15
van gogh,Q28860340,Van Gogh and Expressionism,none,0,0,3.4,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
van gogh,Q111472916,Eiltank 39,none,0,0,1.7,0.69,1.0,0.0,28.8,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.47
van gogh,Q47131712,Van Goghs Schweigen,none,0,0,1.7,0.0,1.0,0.0,26.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.6
van gogh,Q28858120,Van Gogh and the Hague School,none,0,0,4.2,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.13
van gogh,Q5582,Vincent van Gogh,alias,0,1,1.7,5.56,1.0,0.0,33.8,0.0,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,48.54
van gogh,Q34359,Hologramme Médical d'Urgence,alias,0,1,2.5,3.04,3.0,0.0,36.5,0.0,0.167,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,41.6
van gogh,Q7402375,Saintes-Maries,none,0,0,2.5,2.4,1.0,0.0,53.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.59
van gogh,Q205456,Theo van Gogh,alias,0,1,1.7,3.99,1.0,0.0,33.8,0.0,0.5,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,42.25
van gogh,Q77614,Van Gogh,label,1,0,2.5,1.39,1.0,0.0,29.8,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,39.83
van gogh,Q11900334,Van Gogh,label,1,0,1.7,0.69,1.0,0.0,19.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.28
van gogh,Q106378685,Van Gogh marchant à travers champs,none,0,0,1.7,0.0,1.0,0.0,15.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
van gogh,Q19620611,Van Goghstraat,none,0,0,0.8,0.0,1.0,0.0,23.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.05
van gogh,Q106858006,Van Gogh / Artaud. Le suicidé de la société,none,0,0,2.5,0.0,1.0,0.0,23.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.08
van gogh,Q106378974,Van Gogh à la palette,none,0,0,1.7,0.0,1.0,0.0,15.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
van gogh,Q17855191,Van Gogh award,none,0,0,1.7,0.0,0.0,4.0,0.0,43.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.78
van gogh,Q106379850,Van Gogh dessinant (MZS 302),none,0,0,1.7,0.0,1.0,0.0,15.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
van gogh,Q106379820,Van Gogh dessinant (MZS 058),none,0,0,1.7,0.0,1.0,0.0,15.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
van gogh,Q106378969,Van Gogh prédicateur,none,0,0,1.7,0.0,1.0,0.0,15.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
van gogh,Q106378686,Van Gogh dessinant,none,0,0,1.7,0.0,1.0,0.0,15.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.99
van gogh,Q19620622,rue Van Gogh,none,0,0,1.7,0.0,1.0,0.0,23.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.07
van gogh,Q29224378,Van Gogh,label,1,0,1.7,0.0,1.0,0.0,15.3,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.42
van gogh,Q119625610,Van Gogh,label,1,0,1.7,0.0,2.0,0.0,35.2,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,33.86
van gogh,Q56742778,arrêt Van Gogh,alias,0,1,1.7,0.0,1.0,0.0,25.6,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,27.48
van gogh,Q56870723,arrêt Van Gogh,alias,0,1,1.7,0.0,1.0,0.0,25.6,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,27.48
van gogh,Q724377,La Chambre de Van Gogh à Arles,none,0,0,1.7,3.76,1.0,0.0,53.4,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.45
van gogh,Q19363211,Autoportrait à l'oreille bandée,none,0,0,1.7,2.56,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
van gogh,Q2093283,Vincent van Gogh peignant les tournesols,none,0,0,1.7,2.77,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.45
van gogh,Q315318,pont Van-Gogh,none,0,0,0.0,1.95,2.0,0.0,26.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.33
van gogh,Q3450227,rue Van-Gogh,none,0,0,0.0,1.1,1.0,0.0,23.7,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.79
van gogh,Q2198679,Catharinakerk,none,0,0,1.7,1.1,1.0,0.0,16.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.54
van gogh,Q174963,MS Salamis Filoxenia,alias,0,1,2.5,1.39,2.0,0.0,25.3,0.0,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,37.16
paintings,Q3305213,painting,label,1,1,1.7,4.06,1.0,11.0,18.5,48.5,0.333,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,15.0,77.53
paintings,Q18638520,Room 903,none,0,0,2.5,0.69,1.0,0.0,24.4,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.64
paintings,Q60997035,Paintings in the Cleveland Museum of Art in 1945,none,0,0,5.1,1.1,3.0,0.0,31.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.37
paintings,Q56230792,Catalogus of naamlyst van het uytmuntent cabinet Schilderyen nagelaaten en verkogt ten Huyzen van de Heer Willem Lormier op Maandag den 4 July 1763,none,0,0,6.8,0.0,1.0,0.0,25.5,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.69
paintings,Q19009168,Room 902,none,0,0,2.5,0.69,1.0,0.0,24.4,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.44
paintings,Q19912227,Paintings of physicians by Jan Steen,none,0,0,3.4,1.39,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.79
paintings,Q23935775,Paintings from the Chapter House in Sigena,none,0,0,5.9,0.0,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.15
paintings,Q19317659,"paintings of the Italian Renaissance, hall XVIII",none,0,0,3.4,0.69,1.0,0.0,20.8,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.92
paintings,Q63845158,Paintings by Peder Balke,none,0,0,1.7,0.0,1.0,0.0,25.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.09
paintings,Q28553095,Paintings,label,1,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.13
paintings,Q19018198,"Paintings Southern Netherlands, Antwerp, 1550-1580, Room 811 (9)",none,0,0,3.4,0.69,2.0,0.0,32.5,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.34
paintings,Q41189976,Room 734,none,0,0,2.5,0.69,1.0,0.0,24.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.94
paintings,Q50385080,Paintings,label,1,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.13
paintings,Q548688,Paintings of the Months in Palazzo Schifanoia,none,0,0,3.4,1.39,1.0,2.0,19.0,39.4,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.27
paintings,Q29561652,"Italian Paintings: A Catalogue of the Collection of The Metropolitan Museum of Art. Vol. 1, Florentine School/",none,0,0,5.1,0.69,1.0,0.0,36.2,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.61
paintings,Q61456602,Paintings by Rembrandt - room 22,none,0,0,3.4,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.42
paintings,Q1743188,paintings in churches,none,0,0,1.7,1.39,1.0,3.0,22.0,40.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.88
paintings,Q60049546,"Paintings in the Gemäldegalerie, Berlin - Room 38",none,0,0,2.5,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.41
paintings,Q3374401,paintings by Adolf Hitler,none,0,0,2.5,3.26,1.0,0.0,53.4,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.21
paintings,Q79478423,Paintings and Prints by Mallette Dean,none,0,0,5.1,0.0,1.0,0.0,24.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.15
paintings,Q66314559,"Paintings in the Gemäldegalerie, Berlin - Room 39",none,0,0,2.5,0.69,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.41
paintings,Q77144538,"Gemäldegalerie, Berlin - Room 37",none,0,0,2.5,0.69,1.0,0.0,20.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.41
paintings,Q18386044,paintings conservator,none,0,0,5.9,1.61,1.0,2.0,23.8,42.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.5
paintings,Q26789044,paintings by Delacroix in Saint-Sulpice,none,0,0,3.4,0.0,1.0,0.0,46.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.33
paintings,Q107380949,"paintings by Giovanni Battista Tiepolo for San Pascual Baylon, Aranjuez",none,0,0,3.4,1.1,1.0,0.0,31.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.73
paintings,Q63845241,Paintings by mouth (Art & Language),none,0,0,3.4,0.69,1.0,0.0,53.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.25
paintings,Q2574145,Chronology of works by Caravaggio,none,0,0,3.4,3.18,2.0,0.0,32.2,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.58
paintings,Q12484997,Paintings of Water-Moon Avalokiteshvara,none,0,0,1.7,1.1,1.0,0.0,31.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.7
paintings,Q104904932,The Paintings for the Temple,none,0,0,4.2,0.69,1.0,0.0,53.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.77
paintings,Q2473802,Paintings in the Uffizi Gallery,none,0,0,2.5,1.61,1.0,0.0,22.9,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.08
paintings,Q19331941,paintings by Caravaggio in the Contarelli Chapel,none,0,0,5.1,1.61,1.0,0.0,53.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.24
paintings,Q110962690,"Paintings and decorative arts from the former J. G. Collection, Berlin, various art possessions: auction on September 25, 1941 - Berlin, 1941 (translation from German)",none,0,0,6.8,0.0,2.0,0.0,25.3,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.49
paintings,Q107313723,paintings restorer,none,0,0,0.8,0.0,1.0,2.0,23.8,37.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.56
paintings,Q51785321,Paintings in the Museu d'Història de València,none,0,0,5.1,1.39,2.0,0.0,31.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.71
paintings,Q20880571,Paintings of Shikan (Shrine for Poetry) by Seven Masters,none,0,0,5.1,0.69,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.48
paintings,Q29320435,"Paintings of Mary Magdalene and Saint Michael, in Tarascon",none,0,0,5.9,0.69,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.49
paintings,Q59537947,Paintings that Say Something,none,0,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.08
paintings,Q28834630,"Paintings, Drawings and Sculpture Collected by Yale Alumni: An Exhibition",none,0,0,3.4,0.0,1.0,0.0,24.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
paintings,Q2624588,list of works by Titian,none,0,0,3.4,3.0,1.0,0.0,22.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.59
paintings,Q17636020,Madonna and Child Enthroned with Saints,none,0,0,3.4,1.39,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.79
paintings,Q5651740,Tableaux pour la promenade des ducs d'Osuna,none,0,0,3.4,1.61,1.0,0.0,53.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.21
paintings,Q2308597,liste des œuvres de Michel-Ange,none,0,0,1.7,3.04,2.0,0.0,38.0,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.74
paintings,Q3147733,iconographie de Napoléon Ier,none,0,0,1.7,1.39,0.0,4.0,0.0,46.5,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.36
paintings,Q130997791,"Paintings by Jean Hélion, 1928-1964",none,0,0,1.7,0.0,1.0,0.0,26.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.09
paintings,Q11629,art of painting,none,0,0,5.1,5.35,3.0,5.0,41.6,47.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,16.47
paintings,Q296955,oil paint,none,0,0,4.2,3.83,0.0,6.0,0.0,51.7,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.47
paintings,Q861259,painting support,none,0,0,5.9,2.2,0.0,8.0,0.0,52.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.43
paintings,Q174705,oil painting,none,0,0,4.2,4.28,1.0,3.0,24.4,40.8,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.59
paintings,Q29048021,painting by this artist,none,0,0,3.4,0.0,1.0,4.0,24.8,46.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.89
paintings,Q1406161,artistic theme,none,0,0,5.1,2.4,1.0,6.0,24.8,47.2,0.125,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,12.7
paintings,Q15727816,painting series,none,0,0,5.1,0.0,1.0,7.0,24.0,51.4,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,13.25
paintings,Q107105674,mount,none,0,0,5.1,0.0,0.0,2.0,0.0,38.7,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.36
paintings,Q2351962,raster graphics editor,none,0,0,5.1,3.4,2.0,7.0,27.3,48.5,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.01
paintings,Q919348,Chinese painting,none,0,0,1.7,3.47,1.0,5.0,22.8,34.8,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.57
paintings,Q3374341,painting,label,1,0,5.1,2.2,0.0,2.0,0.0,34.1,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,51.73
paintings,Q3300034,painting material,none,0,0,3.4,1.39,0.0,3.0,0.0,48.1,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.8
paintings,Q18573970,group of paintings,none,0,0,7.6,0.0,0.0,7.0,0.0,49.2,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,14.75
paintings,Q1231896,painting technique,none,0,0,2.5,2.2,0.0,2.0,0.0,21.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.02
paintings,Q1772393,history of painting,none,0,0,1.7,3.37,1.0,2.0,25.8,31.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.73
paintings,Q16743958,genre of painting,none,0,0,3.4,1.39,2.0,3.0,40.0,30.7,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.81
paintings,Q3326867,painting movement,none,0,0,2.5,0.69,0.0,3.0,0.0,44.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.55
paintings,Q1683295,Japanese painting,none,0,0,3.4,3.18,1.0,5.0,22.8,34.6,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.96
paintings,Q497976,coloring book,none,0,0,4.2,3.58,0.0,11.0,0.0,48.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,15.37
paintings,Q2898215,Painting,label,1,0,1.7,1.61,1.0,0.0,22.9,0.0,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,36.69
paintings,Q55429518,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q17399019,style of painting,none,0,0,3.4,0.69,1.0,4.0,24.8,48.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.25
paintings,Q27969458,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q19887349,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55414220,painting,label,1,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.13
paintings,Q55421552,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55432005,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55409265,Day of Judgment,none,0,0,2.5,0.0,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.08
paintings,Q55429665,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55432322,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55409421,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55429260,Painting,label,1,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.13
paintings,Q55429168,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55408271,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q3374370,Italian painting,none,0,0,1.7,1.61,1.0,5.0,22.8,34.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.14
paintings,Q617969,The Painting,none,0,0,2.5,1.79,1.0,0.0,40.0,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.35
paintings,Q37545359,Painting,label,1,0,0.8,0.69,1.0,0.0,27.7,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.92
paintings,Q55429056,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55429673,Painting,label,1,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.13
paintings,Q55432105,Painting,label,1,0,2.5,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.13
paintings,Q55429744,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q106775409,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55429253,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q55429030,Painting,label,1,0,1.7,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.59
paintings,Q59569564,Painting,label,1,0,0.8,0.0,1.0,0.0,22.9,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,29.05
paintings,Q1979710,Painting the Century: 101 Portrait Masterpieces 1900-2000,none,0,0,1.7,1.79,1.0,0.0,24.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.98
paintings,Q428306,Painting on a Wall,none,0,0,1.7,1.79,1.0,0.0,20.7,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.94
paintings,Q56085814,Painting Pictures,none,0,0,1.7,0.0,1.0,0.0,21.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.05
paintings,Q6064255,Modèle:Infobox Art,none,0,0,1.7,4.57,1.0,0.0,18.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.31
paintings,Q7125082,Painting the Clouds with Sunshine,none,0,0,1.7,1.1,1.0,0.0,37.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.76
paintings,Q107420080,Dutch painting,none,0,0,3.4,1.79,1.0,5.0,22.8,35.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.28
paintings,Q706846,Séjour dans les Monts Fuchun,none,0,0,4.2,2.83,1.0,0.0,22.9,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.53
paintings,Q1887220,école de peinture,none,0,0,0.8,0.69,0.0,8.0,0.0,47.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.54
cohort,Q2981883,cohort,label,1,0,0.7,2.48,1.0,0.0,18.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,38.39
cohort,Q202167,cohort,label,1,0,0.0,3.89,0.0,2.0,0.0,19.2,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,41.62
cohort,Q1778788,cohort study,none,0,0,1.4,3.37,0.0,3.0,0.0,39.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.64
cohort,Q1303415,cohort,label,1,0,2.7,3.18,0.0,2.0,0.0,21.9,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,48.37
cohort,Q29867328,Cohort,label,1,0,0.0,0.69,1.0,0.0,20.1,0.0,0.5,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,27.21
cohort,Q5141434,Cohort Studios,none,0,0,0.0,1.1,1.0,0.0,25.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.6
cohort,Q7836899,group in an experiment,none,0,0,4.1,2.08,1.0,5.0,18.4,40.0,0.154,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.74
cohort,Q29867340,Cohort 2,none,0,0,0.7,0.69,1.0,0.0,20.1,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.17
cohort,Q17016783,cohort analysis,none,0,0,3.4,1.79,1.0,3.0,29.0,35.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.18
cohort,Q3048982,cohort effect,none,0,0,5.5,1.79,1.0,0.0,29.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.56
cohort,Q107343779,experiment group type,none,0,0,2.1,0.0,2.0,2.0,26.6,18.8,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.88
cohort,Q1409977,Vigiles,none,0,0,0.7,3.0,1.0,0.0,31.4,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
cohort,Q51885294,Cohortales (Pauly-Wissowa),none,0,0,0.7,0.69,1.0,0.0,26.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.23
cohort,Q51264388,cohortes urbanae (Pauly-Wissowa),none,0,0,0.7,0.69,1.0,0.0,21.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.19
cohort,Q51885297,Cohortandus (Pauly-Wissowa),none,0,0,0.7,0.69,1.0,0.0,26.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.23
cohort,Q114270412,Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium,none,0,0,2.1,0.0,1.0,0.0,39.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.66
cohort,Q14193326,Cohort Ladin,none,0,0,0.7,0.0,1.0,0.0,28.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.91
cohort,Q61938178,Cohort Study in Type 2 Diabetes in China,none,0,0,1.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
cohort,Q99530075,"Cohort, Compassionate Use Program for Patients Diagnosed With BRAF V600activating Mutation-positive Advanced NSCLC.",none,0,0,1.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
cohort,Q83806615,Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation,none,0,0,1.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
cohort,Q66042127,Cohort Event Monitoring Study of Pyramax®,none,0,0,0.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.85
cohort,Q61956993,Cohort of Hepatitis B Research of Amsterdam,none,0,0,0.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.85
cohort,Q5141431,cohort,label,1,0,2.7,1.1,0.0,2.0,0.0,25.9,0.286,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,37.27
cohort,Q123421302,cohort,label,1,0,2.7,0.0,0.0,3.0,0.0,24.3,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,37.21
cohort,Q1107163,Cohortes urbanae,none,0,0,1.4,2.94,2.0,2.0,21.5,35.4,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.61
cohort,Q2940964,Cohortes Vigilum,none,0,0,0.0,1.61,1.0,0.0,21.6,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.32
cohort,Q117232128,COhort of GEriatric Nephrology in NTUH (COGENT) study group,none,0,0,1.4,0.0,1.0,0.0,28.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.73
cohort,Q66062539,Cohort Trial on Perioperative Localization Techniques of Parathyroid Adenomas,none,0,0,0.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.85
cohort,Q65544713,Cohort Study for Patients Using Fuzeon (Enfuvirtide),none,0,0,1.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
cohort,Q64220264,Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism,none,0,0,3.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.13
cohort,Q90693208,Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma,none,0,0,1.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
cohort,Q64805162,"Cohort Study to Evaluate Exacerbations, Respiratory Symptoms, Physical Exercise Intolerance and Lung Functions Among Participants Who Use IQOS With Heatsticks Compared to Smokers of Conventional Cigarettes",none,0,0,3.4,0.0,1.0,0.0,22.4,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.13
cohort,Q63572064,Cohort as Part of Undergraduate Medical Studies at the University of Sherbrooke,none,0,0,2.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
cohort,Q63815764,Cohort Study to Assess the Level of Compliance in Undertaking Breast Self Examination Among Women Attending Preventive Oncology Clinic,none,0,0,3.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.13
cohort,Q64663819,Cohort Study: Perceptual Urge Sensation,none,0,0,0.0,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.02
cohort,Q66082468,Cohort Study on A Following-up System of Native Arteriovenous Fistulae,none,0,0,1.4,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.67
cohort,Q64348615,Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction,none,0,0,4.1,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.96
cohort,Q64709987,Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials,none,0,0,2.1,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
cohort,Q66546681,Cohort of STEMI Patients,none,0,0,0.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.85
cohort,Q63813127,"Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin",none,0,0,2.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
cohort,Q62040224,Cohort B of the Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter,none,0,0,2.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
cohort,Q105088910,Cohorte Nationale VIH-2,none,0,0,0.0,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.02
cohort,Q117194504,Cohort Studies of Memory in an International Consortium (COSMIC),none,0,0,2.7,0.0,1.0,0.0,28.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.38
cohort,Q64396365,Cohort Study on Internet Game and Smart Phone Addiction,none,0,0,0.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.85
cohort,Q117863233,"Cohort for Research on Environment, Urban Management and Human Settlement",none,0,0,2.1,0.0,1.0,0.0,26.8,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.53
cohort,Q35749,parlement,none,0,0,0.0,4.94,0.0,10.0,0.0,47.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.85
cohort,Q219692,Cortès générales,none,0,0,0.7,3.93,1.0,4.0,17.5,40.9,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.69
cohort,Q194019,Brigades rouges,none,0,0,0.0,3.89,3.0,0.0,28.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.13
cohort,Q109587149,Cohortes épidémiologiques en population,none,0,0,0.7,0.0,1.0,0.0,28.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.9
cohort,Q181733,garde prétorienne,none,0,0,0.0,4.2,2.0,4.0,36.7,36.4,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.96
cohort,Q55439728,Constances,none,0,0,0.0,0.69,2.0,0.0,34.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.29
cohort,Q3690045,cohors equitata,none,0,0,0.7,1.39,0.0,3.0,0.0,12.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.42
cohort,Q131831799,cohorte auxiliaire,none,0,0,0.0,0.0,0.0,3.0,0.0,21.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.97
cohort,Q66498680,Cohort and Age Effects,none,0,0,0.7,0.0,1.0,0.0,15.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.27
cohort,Q131831810,cohorte de légion,none,0,0,1.4,0.0,0.0,3.0,0.0,21.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.62
longitudinal,Q1758614,longitudinal study,none,0,0,2.1,3.37,0.0,5.0,0.0,43.9,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.5
longitudinal,Q1411024,fibular hemimelia,none,0,0,2.1,2.2,2.0,6.0,35.6,44.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.47
longitudinal,Q51967449,Longitudinal Sur,none,0,0,2.7,1.1,1.0,0.0,27.5,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.91
longitudinal,Q17627190,hemimelia,none,0,0,1.4,1.79,2.0,8.0,35.6,43.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.65
longitudinal,Q626707,longitudinal wave,none,0,0,4.1,3.89,0.0,2.0,0.0,17.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.22
longitudinal,Q89627152,Longitudinal Norte,none,0,0,0.7,1.1,1.0,0.0,27.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.45
longitudinal,Q112058805,longitudinal gradient,none,0,0,2.1,0.0,0.0,4.0,0.0,35.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.15
longitudinal,Q380410,longitudinal axis,none,0,0,4.1,1.61,1.0,0.0,39.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.93
longitudinal,Q1420988,longitudinal cerebral fissure,none,0,0,2.7,2.94,2.0,5.0,36.9,45.9,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.1
longitudinal,Q21113194,longitudinal sarcoplasmic reticulum,none,0,0,2.7,0.0,1.0,2.0,17.1,21.6,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.63
longitudinal,Q42213524,craniocaudal axis,none,0,0,0.7,0.0,0.0,6.0,0.0,43.4,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.77
longitudinal,Q6674015,longitudinal striae of Lancisi,none,0,0,2.1,1.1,1.0,2.0,33.5,12.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.45
longitudinal,Q6674017,Longitudinal static stability,none,0,0,3.4,2.48,0.0,4.0,0.0,38.9,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.56
longitudinal,Q56303303,meridional,none,0,0,1.4,1.39,1.0,0.0,30.6,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.64
longitudinal,Q1031793,Chilean Central Valley,none,0,0,2.7,3.04,1.0,0.0,22.9,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.84
longitudinal,Q6674007,longitudinal framing,none,0,0,1.4,1.61,1.0,0.0,6.6,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.32
longitudinal,Q2458611,longitudinal engine,none,0,0,4.8,2.94,0.0,2.0,0.0,18.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.58
longitudinal,Q1879222,longitudinal straightness,none,0,0,2.1,0.69,2.0,2.0,36.3,34.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.75
longitudinal,Q110163275,Longitudinal Section of the most entire Temple at Baalbec (Legend on separate sheet)(unumbered),none,0,0,3.4,0.0,1.0,0.0,20.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.11
longitudinal,Q114409983,Longitudinal Parkinson's Disease Patient Study Group,none,0,0,1.4,0.0,1.0,0.0,28.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.73
longitudinal,Q66570063,longitudinal pontine tract,none,0,0,0.7,0.0,0.0,2.0,0.0,10.8,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.77
longitudinal,Q1879248,longitudinal valley,none,0,0,1.4,1.61,0.0,5.0,0.0,47.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.83
longitudinal,Q113894627,Longitudinal Study of Frailty in Shanghai Older People,none,0,0,2.1,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
longitudinal,Q92392224,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),none,0,0,2.7,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.31
longitudinal,Q29010150,Longitudinal asthma patterns in a large cohort of US women with 22-year follow-up,none,0,0,5.5,0.0,1.0,0.0,18.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.56
longitudinal,Q115075154,Longitudinal assessment of metabolic syndrome as a modifiable risk factor of World Trade Center particulate matter exposure associated lung disease,none,0,0,4.8,0.0,1.0,0.0,18.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.74
longitudinal,Q39326770,lola,none,0,0,1.4,0.0,1.0,0.0,14.7,0.0,0.069,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.8
longitudinal,Q39559838,Longitudinals lacking Dmel_CG12052,none,0,0,1.4,0.0,1.0,5.0,24.4,38.0,0.031,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.08
longitudinal,Q23909293,Longitudinal decline in FEV1 by GOLD Stage in workers in a spirometry surveillance program,none,0,0,2.7,0.0,1.0,0.0,18.2,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.27
longitudinal,Q110753021,Longitudinal section through the Orangerie in Château de Sceaux in the year 1700.,none,0,0,2.7,0.0,1.0,0.0,19.6,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.28
longitudinal,Q1978718,unité de longueur,alias,0,1,0.7,3.66,0.0,4.0,0.0,42.5,0.4,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,39.55
longitudinal,Q37172,onde,none,0,0,0.0,4.8,0.0,2.0,0.0,34.3,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.87
longitudinal,Q1778788,étude de cohorte,none,0,0,0.7,3.37,0.0,3.0,0.0,39.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.82
longitudinal,Q36477,longitude,alias,0,1,0.7,4.79,0.0,3.0,0.0,34.7,0.667,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,45.06
longitudinal,Q1048134,muscle longitudinal supérieur de la langue,none,0,0,2.1,2.71,2.0,7.0,34.8,48.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.85
longitudinal,Q7908507,vagin cloisonné,none,0,0,0.7,2.4,2.0,7.0,35.6,38.2,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.48
longitudinal,Q147912,muscle longitudinal inférieur de la langue,none,0,0,0.7,2.71,1.0,4.0,4.3,29.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.15
longitudinal,Q6674012,Longitudinal ligament,none,0,0,0.7,1.1,1.0,0.0,24.1,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.41
longitudinal,Q627306,Peru Highway 1,none,0,0,1.4,1.39,1.0,0.0,24.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.38
longitudinal,Q19313060,Peru Highway 5,none,0,0,0.7,1.1,1.0,0.0,24.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
longitudinal,Q17629120,Peru Highway 3N,none,0,0,0.7,1.1,1.0,0.0,24.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
longitudinal,Q3942958,Peru Highway 3,none,0,0,0.7,1.1,1.0,0.0,24.7,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.42
mortality,Q58702,mortality rate,none,0,0,7.5,4.16,2.0,4.0,21.0,39.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,16.64
mortality,Q1239812,mortality,label,1,0,3.4,1.79,0.0,3.0,0.0,39.8,0.667,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,45.4
mortality,Q104778232,COVID-19 mortality,none,0,0,2.7,1.1,0.0,2.0,0.0,48.6,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.18
mortality,Q18035959,MORF4L1,none,0,0,2.7,1.61,1.0,2.0,14.7,21.5,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.01
mortality,Q14402985,mortality,label,1,0,2.7,0.69,1.0,2.0,16.7,42.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,41.2
mortality,Q18034526,MORF4L2,none,0,0,2.7,1.61,1.0,2.0,14.7,21.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.61
mortality,Q31842547,Mortality,label,1,0,0.7,0.69,1.0,0.0,19.0,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,31.24
mortality,Q56852608,Mortality,label,1,0,2.7,0.0,1.0,0.0,27.8,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,34.83
mortality,Q19055587,Mortality,label,1,0,1.4,0.69,1.0,0.0,13.5,0.0,1.0,3.0,4.0,2.0,1.5,2.2,2.0,4.0,20.0,0.0,33.18
mortality,Q6914399,excess mortality,none,0,0,0.7,2.89,0.0,2.0,0.0,48.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.36
mortality,Q6914402,mortality salience,none,0,0,4.8,0.69,0.0,3.0,0.0,37.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.2
mortality,Q21497907,Mortality factor 4 like 1,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.39
mortality,Q54460622,Mortality factor 4-like protein 1,none,0,0,1.4,0.0,1.0,2.0,23.2,26.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.58
mortality,Q21130545,Mortality factor 4 like 1,none,0,0,2.7,0.0,1.0,0.0,24.4,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.0
mortality,Q8326098,poult enteritis mortality syndrome,none,0,0,0.7,0.69,1.0,2.0,13.5,17.2,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.64
mortality,Q29743740,morf4l1,none,0,0,2.7,0.0,1.0,0.0,14.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.73
mortality,Q24412769,Morf4l1,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.61
mortality,Q18254941,Morf4l1,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.36
mortality,Q29680508,mrg-1,none,0,0,2.7,0.0,1.0,0.0,14.7,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.23
mortality,Q26379122,"Mortality among U.S. workers employed in the production of chemicals contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)",none,0,0,4.8,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.74
mortality,Q18258425,Morf4l2,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.46
mortality,Q54460623,Mortality factor 4-like protein 2,none,0,0,1.4,0.0,1.0,2.0,23.2,26.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.58
mortality,Q24392826,Morf4l2,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.11
mortality,Q18307551,Morf4l1b,none,0,0,2.1,0.0,1.0,2.0,14.7,21.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.98
mortality,Q21116368,Mortality factor 4 like 2,none,0,0,2.7,0.0,1.0,0.0,24.4,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.08
mortality,Q632184,life table,none,0,0,2.7,3.18,1.0,0.0,20.8,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.08
mortality,Q21988662,Mortality factor 4 like 2,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.49
mortality,Q26374306,"Mortality analysis of workers exposed to chloroprene, final report for E.I. du Pont de Nemours and Co, Inc",none,0,0,4.1,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.92
mortality,Q61517710,mortality factor 4 protein 1 like,none,0,0,2.1,0.0,1.0,5.0,24.4,38.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.81
mortality,Q26327960,Mortality patterns among fibrous glass production workers - provisional report,none,0,0,2.1,0.0,1.0,0.0,18.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.45
mortality,Q6914401,mortality forecasting,none,0,0,1.4,0.69,0.0,3.0,0.0,39.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.1
mortality,Q3324542,mortality in France,none,0,0,4.8,0.69,1.0,0.0,56.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.47
mortality,Q28555926,Mortality factor 4 like 2,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.49
mortality,Q62315184,Mortality factor 4 protein 1,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.64
mortality,Q113890143,Mortality Score in Elderly Patients With Colon Cancer,none,0,0,2.1,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
mortality,Q26215616,Mortality and industrial hygiene study of workers exposed to polychlorinated biphenyls,none,0,0,3.4,0.0,1.0,0.0,18.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.1
mortality,Q29823591,Mortality factor 4 like 1,none,0,0,2.7,0.0,1.0,0.0,24.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.83
mortality,Q24175139,mortality in Finland,none,0,0,2.7,0.0,1.0,0.0,56.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.65
mortality,Q26248520,Mortality among ferrous foundry workers,none,0,0,1.4,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.63
mortality,Q26372778,Mortality of workers exposed to polychlorinated biphenyls - an update,none,0,0,3.4,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.1
cohorte,Q1409977,Vigiles,none,0,0,0.7,3.0,1.0,0.0,31.4,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.43
cohorte,Q51264388,cohortes urbanae (Pauly-Wissowa),none,0,0,0.7,0.69,1.0,0.0,21.9,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.19
cohorte,Q1107163,Cohortes urbanae,none,0,0,1.4,2.94,2.0,2.0,21.5,35.4,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.61
cohorte,Q2940964,Cohortes Vigilum,none,0,0,0.0,1.61,1.0,0.0,21.6,0.0,0.167,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,2.32
cohorte,Q105088910,Cohorte Nationale VIH-2,none,0,0,0.0,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.02
cohorte,Q18981613,Cohortedreef,none,0,0,1.4,0.0,1.0,0.0,20.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.65
cohorte,Q35749,parliament,none,0,0,0.7,4.94,0.0,10.0,0.0,47.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.68
cohorte,Q2981883,cohort,alias,0,1,0.7,2.48,1.0,0.0,18.0,0.0,1.0,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,36.92
cohorte,Q202167,cohort,none,0,0,0.0,3.89,0.0,2.0,0.0,19.2,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.3
cohorte,Q219692,Cortes Generales,none,0,0,0.7,3.93,1.0,4.0,17.5,40.9,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.69
cohorte,Q194019,Red Brigades,none,0,0,0.0,3.89,3.0,0.0,28.1,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.13
cohorte,Q181733,Praetorian Guard,none,0,0,0.7,4.2,2.0,4.0,36.7,36.4,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.78
cohorte,Q1303415,cohort,alias,0,1,2.7,3.18,0.0,2.0,0.0,21.9,1.0,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,46.26
cohorte,Q3690045,cohors equitata,none,0,0,0.7,1.39,0.0,3.0,0.0,12.7,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.42
cohorte,Q109587149,Population-based epidemiological cohorts,none,0,0,2.7,0.0,1.0,0.0,28.0,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.37
cohorte,Q5141431,cohort,alias,0,1,2.7,1.1,0.0,2.0,0.0,25.9,0.286,3.0,4.0,1.6,1.0,1.8,1.5,8.0,0.0,15.0,32.29
cohorte,Q55439728,cohorte constances,none,0,0,0.0,0.69,2.0,0.0,34.3,0.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.29
cohorte,Q131831799,auxiliary cohort,none,0,0,0.0,0.0,0.0,3.0,0.0,21.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.97
cohorte,Q131831810,legionary cohort,none,0,0,1.4,0.0,0.0,3.0,0.0,21.5,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.62
longitudinale,Q626707,longitudinal wave,none,0,0,4.1,3.89,0.0,2.0,0.0,17.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.22
longitudinale,Q112939590,longitudinal relaxation time,none,0,0,1.4,0.0,0.0,5.0,0.0,46.2,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.51
longitudinale,Q6674008,Longitudinal erythronychia,none,0,0,0.7,1.1,0.0,2.0,0.0,27.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.79
mortalit,Q58702,mortality rate,none,0,0,7.5,4.16,2.0,4.0,21.0,39.1,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,16.64
mortalit,Q104778232,COVID-19 mortality,none,0,0,2.7,1.1,0.0,2.0,0.0,48.6,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.18
mortalit,Q1239812,mortality,none,0,0,3.4,1.79,0.0,3.0,0.0,39.8,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.12
mortalit,Q18035959,MORF4L1,none,0,0,2.7,1.61,1.0,2.0,14.7,21.5,0.2,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.01
mortalit,Q18034526,MORF4L2,none,0,0,2.7,1.61,1.0,2.0,14.7,21.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.61
mortalit,Q6914399,excess mortality,none,0,0,0.7,2.89,0.0,2.0,0.0,48.6,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.36
mortalit,Q6914402,mortality salience,none,0,0,4.8,0.69,0.0,3.0,0.0,37.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.2
mortalit,Q21497907,Mortality factor 4 like 1,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.39
mortalit,Q14402985,mortality,none,0,0,2.7,0.69,1.0,2.0,16.7,42.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.14
mortalit,Q54460622,Mortality factor 4-like protein 1,none,0,0,1.4,0.0,1.0,2.0,23.2,26.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.58
mortalit,Q21130545,Mortality factor 4 like 1,none,0,0,2.7,0.0,1.0,0.0,24.4,0.0,0.222,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.0
mortalit,Q31842547,Mortality,none,0,0,0.7,0.69,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.16
mortalit,Q8326098,poult enteritis mortality syndrome,none,0,0,0.7,0.69,1.0,2.0,13.5,17.2,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.64
mortalit,Q29743740,morf4l1,none,0,0,2.7,0.0,1.0,0.0,14.7,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.73
mortalit,Q24412769,Morf4l1,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.61
mortalit,Q18254941,Morf4l1,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.36
mortalit,Q29680508,mrg-1,none,0,0,2.7,0.0,1.0,0.0,14.7,0.0,0.333,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.23
mortalit,Q26379122,"Mortality among U.S. workers employed in the production of chemicals contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)",none,0,0,4.8,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.74
mortalit,Q18258425,Morf4l2,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.46
mortalit,Q54460623,Mortality factor 4-like protein 2,none,0,0,1.4,0.0,1.0,2.0,23.2,26.1,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.58
mortalit,Q56852608,Mortality,none,0,0,2.7,0.0,1.0,0.0,27.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.37
mortalit,Q24392826,Morf4l2,none,0,0,2.7,0.0,1.0,2.0,14.7,21.5,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.11
mortalit,Q18307551,Morf4l1b,none,0,0,2.1,0.0,1.0,2.0,14.7,21.5,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.98
mortalit,Q21116368,Mortality factor 4 like 2,none,0,0,2.7,0.0,1.0,0.0,24.4,0.0,0.25,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.08
mortalit,Q632184,life table,none,0,0,2.7,3.18,1.0,0.0,20.8,0.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.08
mortalit,Q19055587,Mortality,none,0,0,1.4,0.69,1.0,0.0,13.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.92
mortalit,Q21988662,Mortality factor 4 like 2,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.49
mortalit,Q26374306,"Mortality analysis of workers exposed to chloroprene, final report for E.I. du Pont de Nemours and Co, Inc",none,0,0,4.1,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.92
mortalit,Q61517710,mortality factor 4 protein 1 like,none,0,0,2.1,0.0,1.0,5.0,24.4,38.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.81
mortalit,Q26327960,Mortality patterns among fibrous glass production workers - provisional report,none,0,0,2.1,0.0,1.0,0.0,18.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.45
mortalit,Q6914401,mortality forecasting,none,0,0,1.4,0.69,0.0,3.0,0.0,39.1,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.1
mortalit,Q3324542,mortality in France,none,0,0,4.8,0.69,1.0,0.0,56.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.47
mortalit,Q28555926,Mortality factor 4 like 2,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.49
mortalit,Q62315184,Mortality factor 4 protein 1,none,0,0,2.7,0.0,1.0,5.0,24.4,38.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.64
mortalit,Q113890143,Mortality Score in Elderly Patients With Colon Cancer,none,0,0,2.1,0.0,1.0,0.0,22.4,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.49
mortalit,Q26215616,Mortality and industrial hygiene study of workers exposed to polychlorinated biphenyls,none,0,0,3.4,0.0,1.0,0.0,18.8,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.1
mortalit,Q29823591,Mortality factor 4 like 1,none,0,0,2.7,0.0,1.0,0.0,24.4,0.0,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.83
mortalit,Q24175139,mortality in Finland,none,0,0,2.7,0.0,1.0,0.0,56.5,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.65
mortalit,Q26248520,Mortality among ferrous foundry workers,none,0,0,1.4,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.63
mortalit,Q26372778,Mortality of workers exposed to polychlorinated biphenyls - an update,none,0,0,3.4,0.0,1.0,0.0,19.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,8.1
mortalit,Q61559,mortalité infanto-juvénile,none,0,0,2.7,3.4,0.0,2.0,0.0,48.6,0.286,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.44
mortalit,Q4,mort,none,0,0,0.0,5.44,3.0,2.0,46.4,41.6,0.062,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,7.3
mortalit,Q1324130,animal tué sur la route par un véhicule,none,0,0,2.7,2.71,2.0,6.0,34.9,36.1,0.125,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,10.85
mortalit,Q1339474,mort maternelle,none,0,0,0.0,3.64,1.0,2.0,21.8,42.0,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.37
mortalit,Q2781245,mortalité périnatale,none,0,0,2.7,3.14,0.0,7.0,0.0,44.9,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,11.42
mortalit,Q835884,mortalité infantile,none,0,0,0.7,3.87,1.0,2.0,15.0,47.7,0.5,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,6.79
mortalit,Q3324547,mortalité néonatale,none,0,0,0.7,1.39,1.0,2.0,15.0,32.1,0.667,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,5.92
mortalit,Q7168672,mortalité postopératoire,none,0,0,2.7,1.39,0.0,4.0,0.0,44.9,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.74
mortalit,Q16879561,Mortalité dans le monde,none,0,0,0.0,1.79,1.0,0.0,21.3,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.91
mortalit,Q3324544,Mortalité des prisonniers en France,none,0,0,0.7,0.69,0.0,2.0,0.0,40.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.89
mortalit,Q1471423,décès sur la route,none,0,0,0.7,0.69,0.0,2.0,0.0,42.0,0.4,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,3.9
mortalit,Q3863217,taux de mortalité évitable,none,0,0,3.4,2.4,0.0,2.0,0.0,35.4,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,9.79
mortalit,Q51782809,"Mortalité, Santé, Épidémiologie",none,0,0,0.0,0.0,1.0,0.0,34.0,0.0,1.0,1.2,0.5,0.8,0.6,1.0,0.8,3.0,0.0,0.0,4.14
